<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Single‐dose intravenous diclofenac for acute postoperative pain in adults - McNicol, ED - 2018 | Cochrane Library</title> <meta content="Single‐dose intravenous diclofenac for acute postoperative pain in adults - McNicol, ED - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012498.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Single‐dose intravenous diclofenac for acute postoperative pain in adults - McNicol, ED - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012498.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012498.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Single‐dose intravenous diclofenac for acute postoperative pain in adults" name="citation_title"/> <meta content="Ewan D McNicol" name="citation_author"/> <meta content="ewan.mcnicol@mcphs.edu" name="citation_author_email"/> <meta content="McKenzie C Ferguson" name="citation_author"/> <meta content="Southern Illinois University Edwardsville" name="citation_author_institution"/> <meta content="Roman Schumann" name="citation_author"/> <meta content="Tufts Medical Center" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD012498.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/08/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012498.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012498.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012498.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Pain [*drug therapy]; Analgesics, Opioid [adverse effects]; Anti-Inflammatory Agents, Non-Steroidal [*administration &amp; dosage, adverse effects]; Diclofenac [*administration &amp; dosage, adverse effects]; Injections, Intravenous; Pain, Postoperative [*drug therapy]; Placebos [administration &amp; dosage]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012498.pub2&amp;doi=10.1002/14651858.CD012498.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012498\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012498\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","th","ms","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012498.pub2",title:"Single\\u2010dose intravenous diclofenac for acute postoperative pain in adults",firstPublishedDate:"Aug 28, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012498.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012498.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012498.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012498.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012498.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012498.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012498.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012498.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012498.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012498.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13860 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012498.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-sec-0090"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-sec-0043"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/appendices#CD012498-sec-0102"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/supinfo/CD012498StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/supinfo/CD012498StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Single‐dose intravenous diclofenac for acute postoperative pain in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information#CD012498-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Ewan D McNicol</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information#CD012498-cr-0005">McKenzie C Ferguson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information#CD012498-cr-0006">Roman Schumann</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information/en#CD012498-sec-0111">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 August 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012498.pub2">https://doi.org/10.1002/14651858.CD012498.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012498-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012498-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012498-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012498-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012498-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD012498-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012498-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012498-abs-0001" lang="en"> <section id="CD012498-sec-0001"> <h3 class="title" id="CD012498-sec-0001">Background</h3> <p>Postoperative administration of non‐steroidal anti‐inflammatory drugs (NSAIDs) reduces patient opioid requirements and, in turn, reduces the incidence and severity of opioid‐induced adverse events (AEs). </p> </section> <section id="CD012498-sec-0002"> <h3 class="title" id="CD012498-sec-0002">Objectives</h3> <p>To assess the analgesic efficacy and adverse effects of single‐dose intravenous diclofenac, compared with placebo or an active comparator, for moderate to severe postoperative pain in adults. </p> </section> <section id="CD012498-sec-0003"> <h3 class="title" id="CD012498-sec-0003">Search methods</h3> <p>We searched the following databases without language restrictions: the Cochrane Central Register of Controlled Trials (Cochrane Register of Studies Online), MEDLINE, and Embase on 22 May 2018. We checked clinical trials registers and reference lists of retrieved articles for additional studies. </p> </section> <section id="CD012498-sec-0004"> <h3 class="title" id="CD012498-sec-0004">Selection criteria</h3> <p>We included randomized trials that compared a single postoperative dose of intravenous diclofenac with placebo or another active treatment, for treating acute postoperative pain in adults following any surgery. </p> </section> <section id="CD012498-sec-0005"> <h3 class="title" id="CD012498-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. Two review authors independently considered trials for review inclusion, assessed risk of bias, and extracted data. </p> <p>Our primary outcome was the number of participants in each arm achieving at least 50% pain relief over a four‐ and six‐hour period. </p> <p>Our secondary outcomes were time to, and number of participants using rescue medication; withdrawals due to lack of efficacy, AEs, and for any cause; and number of participants experiencing any AE, serious AEs (SAEs), and NSAID‐related AEs. We performed a post hoc analysis of opioid‐related AEs, to enable indirect comparisons with other analyses of postoperative analgesics. </p> <p>For subgroup analysis, we planned to analyze different doses and formulations of parenteral diclofenac separately. </p> <p>We assessed the overall quality of the evidence for each outcome using GRADE and created two 'Summary of findings' tables. </p> </section> <section id="CD012498-sec-0006"> <h3 class="title" id="CD012498-sec-0006">Main results</h3> <p>We included eight studies, involving 1756 participants undergoing various surgeries (dental, mixed minor, abdominal, and orthopedic), with 20 to 175 participants receiving intravenous diclofenac in each study. Mean study population ages ranged from 24.5 years to 54.5 years. Intravenous diclofenac doses varied among and within studies, ranging from 3.75 mg to 75 mg. Five studies assessed newer formulations of parenteral diclofenac that could be administered as an undiluted intravenous bolus. Most studies had an unclear risk of bias for several domains and a high risk of bias due to small sample size. The overall quality of evidence for each outcome was generally low for reasons including unclear risk of bias in studies, imprecision, and low event numbers. </p> <p><b>Primary outcome</b> </p> <p>Three studies (277 participants) produced a number needed to treat for an additional beneficial outcome (NNTB) for at least 50% of maximum pain relief versus placebo of 2.4 (95% confidence interval (CI) 1.9 to 3.1) over four hours (low‐quality evidence). Four studies (436 participants) produced an NNTB of 3.8 versus placebo (95% CI 2.9 to 5.9) over six hours (low‐quality evidence). No studies provided data for the comparison of intravenous diclofenac with another NSAID over four hours. At six hours there was no difference between intravenous diclofenac and another NSAID (low‐quality evidence). </p> <p><b>Secondary outcomes</b> </p> <p>For secondary efficacy outcomes, intravenous diclofenac was generally superior to placebo and similar to other NSAIDs. </p> <p>For time to rescue medication, comparison of intravenous diclofenac versus placebo demonstrated a median of 226 minutes for diclofenac versus 80 minutes for placebo (5 studies, 542 participants, low‐quality evidence). There were insufficient data for pooled analysis for comparisons of diclofenac with another NSAID (very low‐quality evidence). </p> <p>For the number of participants using rescue medication, two studies (235 participants) compared diclofenac with placebo. The number needed to treat to prevent one additional harmful event (NNTp) (here, the need for rescue medication) compared with placebo was 3.0 (2.2 to 4.5, low‐quality evidence). The comparison of diclofenac with another NSAID included only one study (98 participants). The NNTp was 4.5 (2.5 to 33) for ketorolac versus diclofenac (very low‐quality evidence). </p> <p>The numbers of participants withdrawing were generally low and inconsistently reported (very low‐quality evidence). Participant withdrawals were: 6% (8/140) diclofenac versus 5% (7/128) placebo, and 9% (8/87) diclofenac versus 7% (6/82) another NSAID for lack of efficacy; 2% (4/211) diclofenac versus 0% (0/198) placebo, and 3% (4/138) diclofenac versus 2% (2/129) another NSAID due to AEs; and 11% (21/191) diclofenac versus 17% (30/179) placebo, and 18% (21/118) diclofenac versus 15% (17/111) another NSAID for any cause. </p> <p>Overall adverse event rates were similar between intravenous diclofenac and placebo (71% in both groups, 2 studies, 296 participants) and between intravenous diclofenac and another NSAID (55% and 58%, respectively, 2 studies, 265 participants) (low‐quality evidence for both comparisons). Serious and specific AEs were rare, preventing meta‐analysis. </p> <p>There were sufficient data for a dose‐effect analysis for our primary outcome for only one alternative dose, 18.75 mg. Analysis of the highest dose employed in each study demonstrated a relative benefit compared with placebo of 1.9 (1.4 to 2.4), whereas for the group receiving 18.75 mg, the relative benefit versus placebo was 1.6 (1.2 to 2.1, 2 studies). Compared to another NSAID, the high‐dose analysis demonstrated a relative benefit of 0.9 (0.8 to 1.1), for the group receiving 18.75 mg, the relative benefit was 0.78 (0.65 to 0.93). For direct comparison of high dose versus 18.75 mg, the proportion of participants with at least 50% pain relief was 66% (90/137) for the high‐dose arm versus 57% (77/135) in the low‐dose arm. There were insufficient data for subgroup meta‐analysis of different diclofenac formulations. </p> </section> <section id="CD012498-sec-0007"> <h3 class="title" id="CD012498-sec-0007">Authors' conclusions</h3> <p>The amount and quality of evidence for the use of intravenous diclofenac as a treatment for postoperative pain is low. The available evidence indicates that postoperative intravenous diclofenac administration offers good pain relief for the majority of patients, but further research may impact this estimate. Adverse events appear to occur at a similar rate to other NSAIDs. Insufficient information is available to assess whether intravenous diclofenac has a different rate of bleeding, renal dysfunction, or cardiovascular events versus other NSAIDs. There was insufficient information to evaluate the efficacy and safety of newer versus traditional formulations of intravenous diclofenac. There was a lack of studies in major and cardiovascular surgeries and in elderly populations, which may be at increased risk for adverse events. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012498-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012498-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012498-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012498-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012498-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012498-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012498-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012498-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012498-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD012498-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012498-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012498-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012498-abs-0002" lang="en"> <h3>Single‐dose intravenous diclofenac for short‐term pain after surgery in adults</h3> <p><b>Bottom line</b> </p> <p>There is some evidence that intravenous diclofenac is effective for reducing pain after surgery in adults, but it is less clear how safe it is in this setting. </p> <p><b>Background</b> </p> <p>Pain is common in the short term after surgery. Non‐steroidal anti‐inflammatory drugs (NSAIDs, aspirin‐like drugs) are often given along with opioids (such as morphine) to treat pain. However, NSAIDs may cause bleeding (e.g. at the site of an incision or wound) and injury to the kidneys and gut. Diclofenac is an NSAID that can be given by injection into a vein (intravenously), which may be useful when patients are not able to take medicines by mouth. </p> <p><b>Study characteristics</b> </p> <p>In May 2018, we searched for clinical trials where intravenous diclofenac was used to treat pain after surgery in adults. We found eight studies enrolling a total of 1756 people that met our requirements. The studies were similar in their design, although they were carried out in different surgeries (dental, mixed minor surgeries, abdominal, and orthopedic). The dose of intravenous diclofenac used also varied. Intravenous diclofenac was mostly compared to placebo (a sham treatment, such as a bag of saline administered into a vein) or another NSAID. </p> <p><b>Key findings</b> </p> <p>We were most interested in determining the number of participants with at least half the maximum possible pain relief over four or six hours after treatment. Around twice as many participants had at least half the maximum possible pain relief when they received diclofenac versus those who received placebo. When diclofenac was compared with another NSAID, similar numbers of participants had at least half the maximum possible pain relief. Other assessments, such as how quickly and how many participants needed rescue medication (an extra pain medication available to study participants if the study medication is not treating the participant's pain well enough), and how many participants withdrew from a study, also usually showed that intravenous diclofenac was better than placebo and similar to other NSAIDs. </p> <p>There was insufficient information in the studies to make a good assessment of side effects and serious side effects, but the rate at which they occurred appeared to be similar among all treatments. Very few participants dropped out of the studies because of side effects. This is usually the case in studies where patients are only in a study for a short period of time. </p> <p><b>Quality of the evidence</b> </p> <p>We generally rated the quality of the evidence for each assessment as low due to issues with the design of many of the studies, and low overall numbers of people enrolled. Low‐quality evidence means that further research may have an important impact on our findings. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012498-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012498-sec-0090"></div> <h3 class="title" id="CD012498-sec-0091">Implications for practice</h3> <section id="CD012498-sec-0091"> <section id="CD012498-sec-0092"> <h5 class="title">For adults with moderate to severe postoperative pain</h5> <p>The amount and quality of evidence for the use of diclofenac for treating postoperative pain is low. The evidence we have indicates that postoperative administration of diclofenac offers good pain relief for the majority of patients, but further research may impact this estimate. Adverse events appear to occur at a similar rate to other non‐steroidal anti‐inflammatory drugs (NSAIDs), but information is insufficient to assess whether diclofenac has a different rate of bleeding, renal dysfunction, or cardiovascular events when compared with other NSAIDs. We have insufficient information to confirm that newer formulations of diclofenac are more effective and safer than traditional formulations. </p> </section> <section id="CD012498-sec-0093"> <h5 class="title">For clinicians</h5> <p>The amount and quality of evidence for the use of diclofenac for treating postoperative pain is low. The evidence we have indicates that postoperative administration of diclofenac offers good pain relief for the majority of patients, but further research may impact this estimate. Adverse events appear to occur at a similar rate to other NSAIDs, but information is insufficient to assess whether diclofenac has a different rate of bleeding, renal dysfunction, or cardiovascular events when compared with other NSAIDs. We have insufficient information to confirm that newer formulations of diclofenac are more effective and safer than traditional formulations. </p> </section> <section id="CD012498-sec-0094"> <h5 class="title">For policymakers</h5> <p>The amount and quality of evidence for the use of diclofenac for treating postoperative pain in is low, and policymakers should exercise caution when recommending its use in postoperative guidelines. The evidence we have indicates that postoperative administration of diclofenac offers good pain relief for the majority of patients, but further research may impact this estimate. Adverse events appear to occur at a similar rate to other NSAIDs, but information is insufficient to assess whether diclofenac has a lower rate of bleeding, renal dysfunction, or cardiovascular events when compared with other NSAIDs. We have insufficient information to confirm that newer formulations of diclofenac are more effective and safer than traditional formulations. </p> </section> <section id="CD012498-sec-0095"> <h5 class="title">For funders</h5> <p>The amount and quality of evidence for the use of diclofenac for treating postoperative pain is low. The evidence we have indicates that postoperative administration of diclofenac offers good pain relief for the majority of patients, but further research may impact this estimate. Adverse events appear to occur at a similar rate to other NSAIDs, but information is insufficient to assess whether diclofenac has a lower rate of bleeding, renal dysfunction, or cardiovascular events when compared with other NSAIDs. We also have insufficient information to confirm that newer, more expensive formulations of diclofenac are more effective and safer than traditional formulations, or that any potential differences in efficacy (pain relief, time to onset of analgesia, requirement for rescue analgesia), safety (rate of thrombophlebitis), or administration costs (no requirement for dilution, quicker administration) translate to a lower overall cost of therapy. Similarly, it is unclear whether the increased cost of parenteral formulations of diclofenac versus oral formulations is offset by increased effectiveness and reduced overall costs. </p> </section> </section> <h3 class="title" id="CD012498-sec-0096">Implications for research</h3> <section id="CD012498-sec-0096"> <section id="CD012498-sec-0097"> <h5 class="title">General</h5> <p>While more studies are required to be able to more accurately estimate efficacy and safety of parenteral diclofenac, there is a lack of studies specifically in major and cardiovascular surgeries and in elderly populations. </p> </section> <section id="CD012498-sec-0098"> <h5 class="title">Design</h5> <p>The studies included in our review were designed to detect differences in efficacy between interventions. However, further studies that compare different doses of diclofenac may establish whether doses lower than those currently employed are equally effective. Serious adverse events and adverse events associated with NSAIDs were rare or very rare. Epidemiological studies may more accurately determine the adverse profile of diclofenac in this setting. </p> </section> <section id="CD012498-sec-0099"> <h5 class="title">Outcomes</h5> <p>Endpoints and the pain scoring scales used to assess them in these studies have been extensively validated. The majority of studies assessed pain relief after administration of each intervention, an outcome shown to be clinically important to patients. While the cost of newer formulations of parenteral diclofenac varies between (and in some cases within) countries, it is typically considerably higher than older formulations or oral formulations. Studies conducting cost‐benefit analyses may determine whether this increased cost is offset by increased effectiveness and reduced overall costs. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012498-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012498-sec-0008"></div> <div class="table" id="CD012498-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intravenous diclofenac compared to placebo for acute postoperative pain in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intravenous diclofenac (37.5 mg to 75 mg) compared to placebo for acute postoperative pain in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries<br/><b>Settings:</b> Hospital or community<br/><b>Intervention:</b> Intravenous diclofenac (37.5 mg to 75 mg)<br/><b>Comparison:</b> Placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Probable outcome with</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect and NNTB or NNTH (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Diclofenac</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 4 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>228 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>643 per 1000</b><br/>(458 to 905) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.8</b> (2.0 to 4.0) </p> <p><b>NNTB 2.4</b> (1.9 to 3.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 6 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>336 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>592 per 1000</b><br/>(478 to 730) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.8</b> (1.4 to 2.2) </p> <p><b>NNTB 3.8</b> (2.9 to 5.9) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>436<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (or mean) time to use of rescue medication</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 80 minutes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 226 minutes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>542</p> <p>(5 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants using rescue medication over 4 to 6 hours postinterventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>810 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>478 per 1000</b><br/>(389 to 592) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.59</b> (0.48 to 0.73) </p> <p><b>NNTp</b> <b>3.0</b> (2.2 to 4.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants reporting any adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>709 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>702 per 1000</b><br/>(610 to 809) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> (0.86 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>296<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing a serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b><br/>(1 to 31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.0</b> (0.15 to 7.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>472<br/>(5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Studies underpowered to detect these events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome; NNTH: number needed to treat for an additional harmful outcome; NNTp: number needed to treat to prevent one event; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Unclear risk of bias in several domains.<br/><sup>2</sup>Unexplained heterogeneity.<br/><sup>3</sup>Total number of participants &lt; 400.<br/><sup>4</sup>Large magnitude of effect: RR &gt; 2.<br/><sup>5</sup>Imprecision: unable to estimate confidence intervals due to reporting of median data.<br/><sup>6</sup>Very low number of events. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012498-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous diclofenac compared to another NSAID for acute postoperative pain in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intravenous diclofenac (37.5 mg or 75 mg) compared to another NSAID for acute postoperative pain in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries<br/><b>Settings:</b> Hospital or community<br/><b>Intervention:</b> Intravenous diclofenac (37.5 mg or 75 mg) </p> <p><b>Comparison:</b> Another NSAID </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Probable outcome with</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect and NNTB or NNTH (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Another NSAID</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Diclofenac</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 4 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed as very low quality due to lack of data.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 6 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>767 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>721 per 1000</b><br/>(637 to 813) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> (0.83 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>360<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (or mean) time to use of rescue medication</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 255 minutes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 144 minutes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants using rescue medication over 4 to 6 hours postinterventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>470 per 1000</b><br/>(266 to 830) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.8</b> (1.0 to 3.3) </p> <p>NNTH <b>4.5</b> (2.5 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants reporting any adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>577 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>537 per 1000</b><br/>(473 to 612) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.93</b> (0.82 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing a serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b><br/>(1 to 32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> (0.13 to 6.6) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>423<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Studies underpowered to detect these events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome; NNTH: number needed to treat for an additional harmful outcome; NSAID: non‐steroidal anti‐inflammatory drug; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Unclear risk of bias in several domains.<br/><sup>2</sup>Total number of participants &lt; 400.<br/><sup>3</sup>Imprecision: unable to estimate confidence intervals due to reporting of median data.<br/><sup>4</sup>Fewer than 400 participants in unpublished studies required to change the NNTB to an unacceptably high level of 10.<br/><sup>5</sup>Very low number of events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012498-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012498-sec-0009"></div> <p>The methodology and sections of the text in this protocol are derived from a series of reviews published in the Cochrane Library that assess single or combined analgesic agents for postoperative pain, and from suggested wording from the Cochrane Pain, Palliative and Supportive Care Review Group (<a href="./references#CD012498-bbs2-0083" title="DerryS , CooperTE , PhillipsT . Single fixed-dose oral dexketoprofen plus tramadol for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2016, Issue 6. Art. No: CD012232. [DOI: 10.1002/14651858.CD012232]">Derry 2016</a>). </p> <section id="CD012498-sec-0010"> <h3 class="title" id="CD012498-sec-0010">Description of the condition</h3> <p>Patients frequently experience pain after surgery. Evidence indicates that around 80% of patients experience postoperative pain and that 75% of patients report pain of moderate or greater severity (<a href="./references#CD012498-bbs2-0071" title="ChouR , GordonDB , deLeon-CasasolaOA , RosenbergJM , BicklerS , BrennanT , et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. Journal of Pain2016;17(2):131-57.">Chou 2016</a>). Many patients receive suboptimal perioperative analgesia, which affects quality of life, functioning, and time to recovery, and places them at risk for developing acute postsurgical complications and persistent postsurgical pain (<a href="./references#CD012498-bbs2-0065" title="ApfelbaumJL , ChenC , MehtaSS , GanTJ . Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesthesia and Analgesia2003;97(2):534-40.">Apfelbaum 2003</a>; <a href="./references#CD012498-bbs2-0071" title="ChouR , GordonDB , deLeon-CasasolaOA , RosenbergJM , BicklerS , BrennanT , et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. Journal of Pain2016;17(2):131-57.">Chou 2016</a>). </p> <p>As noted, this review is based on a series of reviews published in the Cochrane Library whose aim is to increase awareness of the range of analgesics that are potentially available, and present evidence for relative analgesic efficacy through indirect comparisons with placebo, in very similar trials performed in a standard manner, with very similar outcomes, and over the same duration. Such relative analgesic efficacy does not in itself determine choice of drug for any situation or person, but guides policymaking at the local level. The series covers all analgesics licensed for acute postoperative pain in the UK, and metamizol, which is commonly used in Spain, Portugal, and Latin American countries. The results have been examined in overviews of efficacy and harm (<a href="./references#CD012498-bbs2-0113" title="MooreRA , DerryS , AldingtonD , WiffenPJ . Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2015, Issue 9. Art. No: CD008659. [DOI: 10.1002/14651858.CD008659.pub3]">Moore 2015a</a>; <a href="./references#CD012498-bbs2-0114" title="MooreRA , DerryS , AldingtonD , WiffenPJ . Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2015, Issue 10. Art. No: CD011407. [DOI: 10.1002/14651858.CD011407.pub2]">Moore 2015b</a>), and related individual reviews include ibuprofen (<a href="./references#CD012498-bbs2-0078" title="DerryC , DerryS , MooreRA , McQuayHJ . Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. Art. No: CD001548. [DOI: 10.1002/14651858.CD001548.pub2]">Derry 2009</a>), paracetamol (acetaminophen) (<a href="./references#CD012498-bbs2-0120" title="TomsL , McQuayHJ , DerryS , MooreRA . Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD004602. [DOI: 10.1002/14651858.CD004602.pub2]">Toms 2008</a>), ketoprofen and dexketoprofen (<a href="./references#CD012498-bbs2-0068" title="BardenJ , DerryS , McQuayHJ , MooreRA . Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2009, Issue 4. Art. No: CD007355. [DOI: 10.1002/14651858.CD007355.pub2]">Barden 2009</a>), codeine (<a href="./references#CD012498-bbs2-0079" title="DerryS , MooreRA , McQuayHJ . Single dose oral codeine, as a single agent, for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2010, Issue 4. Art. No: CD008099. [DOI: 10.1002/14651858.CD008099.pub2]">Derry 2010</a>), and combinations such as ibuprofen plus paracetamol (<a href="./references#CD012498-bbs2-0080" title="DerryCJ , DerryS , MooreRA . Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain. Cochrane Database of Systematic Reviews2013, Issue 6. Art. No: CD010210. [DOI: 10.1002/14651858.CD010210.pub2]">Derry 2013a</a>), ibuprofen plus codeine (<a href="./references#CD012498-bbs2-0081" title="DerryS , KarlinSM , MooreRA . Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD010107. [DOI: 10.1002/14651858.CD010107.pub2]">Derry 2013b</a>), and paracetamol plus codeine (<a href="./references#CD012498-bbs2-0121" title="TomsL , DerryS , MooreRA , McQuayHJ . Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database of Systematic Reviews2009, Issue 1. Art. No: CD001547. [DOI: 10.1002/14651858.CD001547.pub2]">Toms 2009</a>). </p> </section> <section id="CD012498-sec-0011"> <h3 class="title" id="CD012498-sec-0011">Description of the intervention</h3> <section id="CD012498-sec-0012"> <h4 class="title">Acute‐pain trials</h4> <p>Single‐dose trials in acute pain are commonly short in duration, rarely lasting longer than 12 hours. The numbers of participants are small, allowing no reliable conclusions to be drawn about safety. To show that the analgesic is working, it is necessary to use placebo (<a href="./references#CD012498-bbs2-0100" title="McQuayHJ , MooreRA . Placebo. Postgraduate Medical Journal2005;81(953):155-60. [DOI: 10.1136/pgmj.2004.024737]">McQuay 2005</a>). There are clear ethical considerations in doing this. These ethical considerations are addressed by using acute‐pain situations where the pain is expected to go away, and by providing additional analgesia, commonly called rescue analgesia, if the pain has not diminished after about one hour. This is reasonable, because not all participants given an analgesic will have significant pain relief. Approximately 18% of participants given placebo will have significant pain relief (<a href="./references#CD012498-bbs2-0109" title="MooreA , McQuayH . Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006. [ISBN: 0-19-856604-2]">Moore 2006</a>), and up to 50% may have inadequate analgesia with active medicines. Hence, the use of additional or rescue analgesia is important for all participants in the trials. </p> <p>Clinical trials measuring the efficacy of analgesics in acute pain have been standardized over many years (<a href="./references#CD012498-bbs2-0101" title="McQuayHJ , DerryS , EcclestonC , WiffenPJ , MooreRA . Evidence for analgesic effect in acute pain—50 years on. Pain2012;153(7):1364-7. [DOI: 10.1016/j.pain.2012.01.024]">McQuay 2012</a>). Trials have to be randomized and double‐blind. Typically, in the first few hours or days after an operation, patients develop pain that is moderate to severe in intensity, and will then be given the test analgesic or placebo. Pain is measured using standard pain intensity scales immediately before the intervention, and then using pain intensity and pain relief scales over the following four to six hours for shorter‐acting drugs, and up to 12 or 24 hours for longer‐acting drugs. Pain relief of half the maximum possible pain relief or better (at least 50% pain relief) is typically regarded as a clinically useful outcome (<a href="./references#CD012498-bbs2-0111" title="MooreRA , StraubeS , PaineJ , DerryS , McQuayHJ . Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain2011;152(5):982-9. [DOI: 10.1016/j.pain.2010.11.030]">Moore 2011a</a>). For patients given rescue medication, it is usual for no additional pain measurements to be made, and for all subsequent measures to be recorded as initial pain intensity or baseline (zero) pain relief (baseline observation carried forward, BOCF). This process ensures that analgesia from the rescue medication is not wrongly ascribed to the test intervention. In some trials the last observation is carried forward (LOCF), which gives an inflated response for the test intervention compared to placebo, but the effect has been shown to be negligible over four to six hours (<a href="./references#CD012498-bbs2-0108" title="MooreRA , EdwardsJE , McQuayHJ . Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain2005;116(3):322-31. [DOI: 10.1016/j.pain.2005.05.001]">Moore 2005</a>). Patients usually remain in the hospital or clinic for at least the first six hours following the intervention, with measurements supervised, although they may then be allowed home to make their own measurements in trials of longer duration. </p> <p>Knowing the relative efficacy of different analgesic drugs at various doses can be helpful (<a href="./references#CD012498-bbs2-0114" title="MooreRA , DerryS , AldingtonD , WiffenPJ . Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2015, Issue 10. Art. No: CD011407. [DOI: 10.1002/14651858.CD011407.pub2]">Moore 2015b</a>). </p> </section> <section id="CD012498-sec-0013"> <h4 class="title">Recommendations for non‐steroidal anti‐inflammatory drug use in postoperative guidelines</h4> <p>Treatment guidelines for acute pain developed by major professional organizations recommend a multimodal approach to analgesia, which routinely includes administration of both an opioid and one or more non‐opioids, the latter of which frequently includes a non‐steroidal anti‐inflammatory drug (NSAID) (<a href="./references#CD012498-bbs2-0071" title="ChouR , GordonDB , deLeon-CasasolaOA , RosenbergJM , BicklerS , BrennanT , et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. Journal of Pain2016;17(2):131-57.">Chou 2016</a>; <a href="./references#CD012498-bbs2-0097" title="MacintyrePE , SchugSA , ScottDA , VisserEJ , WalkerSM , APM: SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management: Scientific Evidence. 3rd edition. Melbourne: ANZCA &amp; FPM, 2010.">Macintyre 2010</a>). Postoperative administration of NSAIDs has been shown to reduce patient requirements for opioids and, in turn, to reduce the incidence and severity of opioid‐induced adverse events (AEs) (<a href="./references#CD012498-bbs2-0070" title="CepedaMS , CarrDB , MirandaN , DiazA , SilvaC , MoralesO . Comparison of morphine, ketorolac, and their combination for postoperative pain. Results from a large, randomized, double-blind trial. Anesthesiology2005;103(6):1225-32.">Cepeda 2005</a>). Parenteral analgesics are required postoperatively if patients are unable to tolerate oral medications. Until recently, the only parenteral NSAID available in the USA and many other countries was ketorolac. Parenteral ketorolac has demonstrated efficacy in reducing pain and opioid requirements (<a href="./references#CD012498-bbs2-0070" title="CepedaMS , CarrDB , MirandaN , DiazA , SilvaC , MoralesO . Comparison of morphine, ketorolac, and their combination for postoperative pain. Results from a large, randomized, double-blind trial. Anesthesiology2005;103(6):1225-32.">Cepeda 2005</a>). However, its acute safety profile includes increased risk of gastrointestinal bleeding and renal events, particularly with use beyond five days and in at‐risk populations, thought to be due to in part to its selectivity for the cyclooxygenase‐1 (COX‐1) enzyme (<a href="./references#CD012498-bbs2-0084" title="FeldmanHI , KinmanJL , BerlinJA , HennessyS , KimmelSE , FarrarJ , et al. Parenteral ketorolac: the risk for acute renal failure. Annals of Internal Medicine1997;126(3):193-9.">Feldman 1997</a>; <a href="./references#CD012498-bbs2-0118" title="StromBL , BerlinJA , KinmanJL , SpitzPW , HennessyS , FeldmanH , et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: a postmarketing surveillance study. JAMA1996;275(5):376-82.">Strom 1996</a>). Parenteral formulations of the commonly used NSAIDs ibuprofen and diclofenac have been developed, expanding the menu of NSAID agents for treating postoperative pain in patients who require intravenous (IV) analgesia (<a href="./references#CD012498-bbs2-0023" title="DanielsSE , GanTJ , HamiltonDA , SinglaN , LacouturePG , JohnsonO , et al. A pooled analysis evaluating renal safety in placebo- and active comparator-controlled Phase III trials of multiple-dose injectable HPβCD-diclofenac in subjects with acute postoperative pain. Pain Medicine2016;17(12):2378-88. ">Daniels 2016</a>; <a href="./references#CD012498-bbs2-0098" title="McCormackPL , ScottLJ . Diclofenac sodium injection (Dyloject): in postoperative pain. Drugs2008;68(1):123-30.">McCormack 2008</a>; <a href="./references#CD012498-bbs2-0117" title="ScottLJ . Intravenous ibuprofen: in adults for pain and fever. Drugs2012;72(8):1099-109.">Scott 2012</a>). </p> </section> <section id="CD012498-sec-0014"> <h4 class="title">Parenteral diclofenac</h4> <p>Diclofenac, first introduced in Europe in 1973, has an established role in the treatment of acute and chronic pain (<a href="./references#CD012498-bbs2-0023" title="DanielsSE , GanTJ , HamiltonDA , SinglaN , LacouturePG , JohnsonO , et al. A pooled analysis evaluating renal safety in placebo- and active comparator-controlled Phase III trials of multiple-dose injectable HPβCD-diclofenac in subjects with acute postoperative pain. Pain Medicine2016;17(12):2378-88. ">Daniels 2016</a>; <a href="./references#CD012498-bbs2-0094" title="HoySM . Diclofenac sodium bolus injection (Dyloject): a review in acute pain management. Drugs2016;76(12):1213-20.">Hoy 2016</a>; <a href="./references#CD012498-bbs2-0119" title="ToddPA , SorkinEM . Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs1988;35(3):244-85.">Todd 1988</a>). It has analgesic, antipyretic, and anti‐inflammatory properties. In its oral formulation, it has demonstrated limited efficacy in the treatment of acute postoperative pain (<a href="./references#CD012498-bbs2-0082" title="DerryS , WiffenPJ , MooreRA . Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2015, Issue 7. Art. No: CD004768. [DOI: 10.1002/14651858.CD004768]">Derry 2015</a>). A parenteral formulation of diclofenac has been available outside of the USA for several decades (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>). Due to diclofenac’s poor solubility, this formulation contains the solubilizing agents benzyl alcohol and propylene glycol. The use of these solubilizers further necessitates that the drug be administered intramuscularly; or if administered intravenously, that it be further diluted and buffered (with sodium bicarbonate) before administration via slow infusion over 30 to 120 minutes, in order to prevent venous irritation. These added steps may delay analgesia, potentially limiting this formulation’s role in acute postoperative pain management. Recently developed formulations of parenteral diclofenac employ hydroxypropyl‐β‐cyclodextrin (HPβCD) as a solubility enhancer. These formulations do not require further dilution or buffering and may be administered as bolus IV (Dyloject) or subcutaneous (Akis, Dicloin) injections (<a href="./references#CD012498-bbs2-0094" title="HoySM . Diclofenac sodium bolus injection (Dyloject): a review in acute pain management. Drugs2016;76(12):1213-20.">Hoy 2016</a>). </p> </section> </section> <section id="CD012498-sec-0015"> <h3 class="title" id="CD012498-sec-0015">How the intervention might work</h3> <p>Non‐steroidal anti‐inflammatory drugs inhibit COX isoenzymes 1 and 2, thereby reducing the formation of prostaglandins that are responsible for pain and inflammation at a site of injury or disease (<a href="./references#CD012498-bbs2-0085" title="FitzGeraldGA , PatronoC . The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine2001;345(6):433-42. [DOI: 10.1056/NEJM200108093450607]">FitzGerald 2001</a>). In addition to their peripheral effects, NSAIDs act in the spinal cord and central nervous system to reduce pain even when inflammation is not present. They also act upon inflammatory pathways other than those involving COX. Diclofenac shares these properties, and additionally is thought to increase β‐endorphin levels and inhibit the N‐methyl‐D‐aspartate (NMDA) pathway (<a href="./references#CD012498-bbs2-0087" title="GanTJ . Diclofenac: an update on its mechanism of action and safety profile. Current Medical Research and Opinion2010;26(7):1715-31.">Gan 2010</a>). </p> <p>Inhibition of COX may also play a role in the AE profile of NSAIDs. Non‐steroidal anti‐inflammatory drugs account for more reports of drug toxicity than any other agents (<a href="./references#CD012498-bbs2-0092" title="HawkeyCJ . Cyclooxygenase inhibition: between the devil and the deep blue sea. Gut2002;50 Suppl 3:iii25-30.">Hawkey 2002</a>). Risk factors for toxicity include dose, duration of therapy, patient age, and pre‐existing renal impairment. At least two forms of COX are expressed in tissues: COX‐1 is responsible for the production of prostaglandins that play a predominately protective role in the gastrointestinal tract, vascular system, and kidneys, and for the production of thromboxane A2, which is responsible for platelet aggregation and vasoconstriction (<a href="./references#CD012498-bbs2-0086" title="FitzGeraldGA . Coxibs and cardiovascular disease. New England Journal of Medicine2004;351(17):1709-11.">FitzGerald 2004</a>); COX‐2 is expressed constitutively only in the central nervous system and kidneys, but in other organs it is induced after trauma (including surgery) and inflammation. Inhibition of the production of protective prostaglandins and thromboxane may lead to gastrointestinal, hematological, cardiovascular, and renal AEs. Postoperative patients are at greater risk of developing NSAID‐induced acute kidney injury as they may be volume depleted, as are the elderly, who rely on prostaglandins to maintain renal function. Non‐steroidal anti‐inflammatory drugs that selectively inhibit the COX‐2 isoenzyme or that have a balanced COX‐1/COX‐2 profile may reduce the incidence of gastrointestinal bleeding and interfere less with platelet aggregation in comparison to NSAIDs that are selective for COX‐1 (such as ketorolac) (<a href="./references#CD012498-bbs2-0085" title="FitzGeraldGA , PatronoC . The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine2001;345(6):433-42. [DOI: 10.1056/NEJM200108093450607]">FitzGerald 2001</a>; <a href="./references#CD012498-bbs2-0086" title="FitzGeraldGA . Coxibs and cardiovascular disease. New England Journal of Medicine2004;351(17):1709-11.">FitzGerald 2004</a>). Conversely, NSAIDs that are selective for COX‐2 may increase the risk of a cardiovascular event. Non‐steroidal anti‐inflammatory drugs may also occasionally produce liver damage, particularly with long‐term use (<a href="./references#CD012498-bbs2-0066" title="American Pain Society (APS). Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 6th edition. Glenview, IL: APS, 2008.">APS 2008</a>). </p> </section> <section id="CD012498-sec-0016"> <h3 class="title" id="CD012498-sec-0016">Why it is important to do this review</h3> <p>The recent reformulation of parenteral diclofenac has led to a renewed interest in the use of this agent in the perioperative setting. The newer formulation may provide a more rapid onset of analgesia than traditional formulations. In theory, diclofenac’s balanced COX‐1/COX‐2 profile may reduce the risk of development of acute postoperative AEs as observed with ketorolac, such as gastrointestinal bleeding. Studies in healthy volunteers have suggested a reduced risk of platelet dysfunction compared with COX‐1 selective NSAIDs (<a href="./references#CD012498-bbs2-0069" title="BauerKA , GersonW , WrightC , WangJ , McNicolE , LanierRK , et al. Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. Journal of Clinical Anesthesia2010;22(7):510-8.">Bauer 2010</a>), and pooled analyses of safety data from clinical trials have demonstrated a reduction in the rate of thrombophlebitis versus traditional formulations of parenteral diclofenac, and similar rates of renal dysfunction to placebo (<a href="./references#CD012498-bbs2-0074" title="ColucciRD , WrightC , MermelsteinFH , GawareckiDG , CarrDB . Dyloject, a novel injectable diclofenac solubilised with cyclodextrin: reduced incidence of thrombophlebitis compared to injectable diclofenac solubilised with polyethylene glycol and benzyl alcohol. Acute Pain2009;11(1):15-21.">Colucci 2009</a>; <a href="./references#CD012498-bbs2-0023" title="DanielsSE , GanTJ , HamiltonDA , SinglaN , LacouturePG , JohnsonO , et al. A pooled analysis evaluating renal safety in placebo- and active comparator-controlled Phase III trials of multiple-dose injectable HPβCD-diclofenac in subjects with acute postoperative pain. Pain Medicine2016;17(12):2378-88. ">Daniels 2016</a>). However, no systematic reviews to date have assessed the efficacy or safety of this agent. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012498-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012498-sec-0017"></div> <p>To assess the analgesic efficacy and adverse effects of single‐dose intravenous diclofenac, compared with placebo or an active comparator, for moderate to severe postoperative pain in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012498-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012498-sec-0018"></div> <section id="CD012498-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012498-sec-0020"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials with at least 10 participants randomly allocated to each treatment group and double‐blind assessment of participant outcomes. We included multiple‐dose studies if appropriate data from the first dose were available, and cross‐over studies provided that data from the first phase were presented separately or could be obtained. </p> <p>We excluded:</p> <p> <ul id="CD012498-list-0001"> <li> <p>review articles, case reports, and clinical observations;</p> </li> <li> <p>studies of experimental pain;</p> </li> <li> <p>studies of less than four hours' duration or studies that did not present data over four to six hours postdose; </p> </li> <li> <p>studies where pain was not patient‐reported.</p> </li> </ul> </p> <p>For postpartum pain, we included studies if the pain investigated was due to episiotomy or Caesarean section irrespective of the presence of uterine cramps; we excluded studies investigating pain due to uterine cramps alone. </p> <p>We required full journal publication, with the exception of online clinical trial results, summaries of otherwise unpublished clinical trials, and abstracts with sufficient data for analysis. </p> </section> <section id="CD012498-sec-0021"> <h4 class="title">Types of participants</h4> <p>We included studies of adults (aged 18 years and above) with established postoperative pain of moderate to severe intensity following day surgery or inpatient surgery. For studies using a visual analogue scale (VAS) (see Glossary: <a href="./appendices#CD012498-sec-0103">Appendix 1</a>), we considered that pain intensity of greater than 30 mm equates to pain of at least moderate intensity (<a href="./references#CD012498-bbs2-0072" title="CollinsSL , MooreRA , McQuayHJ . The visual analogue pain intensity scale: what is moderate pain in millimetres?Pain1997;72(1–2):95-7. [DOI: 10.1016/S0304-3959(97)00005-5]">Collins 1997</a>). </p> </section> <section id="CD012498-sec-0022"> <h4 class="title">Types of interventions</h4> <p>Diclofenac, administered as a single IV dose, for the relief of acute postoperative pain, and compared to placebo or any active comparator. </p> </section> <section id="CD012498-sec-0023"> <h4 class="title">Types of outcome measures</h4> <section id="CD012498-sec-0024"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012498-list-0002"> <li> <p>Participants achieving at least 50% pain relief over a four‐ to six‐hour period.</p> </li> </ul> </p> </section> <section id="CD012498-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012498-list-0003"> <li> <p>Median (or mean) time to use of rescue medication.</p> </li> <li> <p>Number of participants using rescue medication over a four‐ to six‐hour period.</p> </li> <li> <p>Withdrawals due to lack of efficacy, AEs, and for any cause.</p> </li> <li> <p>Participants experiencing any AE.</p> </li> <li> <p>Participants experiencing any serious AE (SAE). Serious adverse events typically include any untoward medical occurrence or effect that at any dose results in death, is life‐threatening, requires hospitalization or prolongation of existing hospitalization, results in persistent or significant disability or incapacity, is a congenital anomaly or birth defect, is an 'important medical event' that may jeopardize the patient, or may require an intervention to prevent one of the above characteristics or consequences. </p> </li> <li> <p>Specific AEs, particularly renal dysfunction, cardiovascular events, bleeding, and thrombophlebitis. </p> </li> </ul> </p> <p>In addition, we performed a post hoc analysis of AEs that might be considered to be related to opioid use, in an attempt to enable indirect comparisons with other analyses of postoperative analgesics. A reduction in opioid requirements with an effective analgesic may, in turn, reduce the incidence of opioid‐induced side effects. We assessed the following opioid‐related AEs: </p> <p> <ul id="CD012498-list-0004"> <li> <p>nausea;</p> </li> <li> <p>vomiting;</p> </li> <li> <p>nausea and vomiting;</p> </li> <li> <p>pruritus;</p> </li> <li> <p>respiratory depression;</p> </li> <li> <p>sedation;</p> </li> <li> <p>urinary retention;</p> </li> <li> <p>allergic reaction/rash.</p> </li> </ul> </p> </section> </section> </section> <section id="CD012498-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012498-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases without language restrictions.</p> <p> <ul id="CD012498-list-0005"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Register of Studies Online on 22 May 2018. </p> </li> <li> <p>MEDLINE &amp; Medline in Process (via Ovid) 1946 to May, week 2, 2018.</p> </li> <li> <p>Embase (via Ovid) 1974 to 2018, week 21.</p> </li> </ul> </p> <p>MeSH or equivalent and text word terms were used. Searches were tailored to individual databases. The search strategies for MEDLINE, CENTRAL, and Embase are in <a href="./appendices#CD012498-sec-0104">Appendix 2</a>, <a href="./appendices#CD012498-sec-0105">Appendix 3</a>, and <a href="./appendices#CD012498-sec-0106">Appendix 4</a>, respectively. </p> </section> <section id="CD012498-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We searched the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) for ongoing or completed trials on 22 May 2018. In addition, we checked reference lists of reviews and retrieved articles for additional studies and performed citation searches on key articles. We contacted experts in the field for unpublished and ongoing trials. We contacted study authors where necessary for additional information. </p> </section> </section> <section id="CD012498-sec-0029"> <h3 class="title" id="CD012498-sec-0029">Data collection and analysis</h3> <section id="CD012498-sec-0030"> <h4 class="title">Selection of studies</h4> <p>We performed each stage of study selection in duplicate and checked for agreement between us. We determined eligibility by reading the abstract of each study identified by the search. We eliminated studies that clearly did not satisfy the inclusion criteria, and we obtained full copies of the remaining studies. Two review authors (a combination of two of EM, MF, and RS) read these studies independently and reached agreement by discussion. Where agreement could not be reached, the third review author adjudicated. We did not anonymize the studies in any way before assessment. </p> <p>We have included a PRISMA flow chart, which shows the status of identified studies (<a href="./references#CD012498-bbs2-0102" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097.">Moher 2009</a>), as recommended in Section 11.2.1 of the <i>Cochrane Handbook</i> <i>for Systematic Reviews of Intervention</i> (<a href="./references#CD012498-bbs2-0093" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We included studies in the review irrespective of whether measured outcome data were reported in a 'usable' way. </p> </section> <section id="CD012498-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (a combination of two of EM, MF, and RS) independently extracted data using a standardised form and checked for agreement before entry into Review Manager 5 (<a href="./references#CD012498-bbs2-0116" title="Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). We collated multiple reports of the same study, so that each study, rather than each report, was the unit of interest in the review. We collected information about the included studies (e.g. study methods, study population, baseline pain intensity) in sufficient detail to complete a 'Characteristics of included studies' table. </p> </section> <section id="CD012498-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (a combination of EM, MF, and RS) independently assessed risk of bias for each study, using applicable criteria outlined in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012498-bbs2-0093" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>), and adapted from those used by the Cochrane Pregnancy and Childbirth Group, with any disagreements resolved by discussion. We completed a 'Risk of bias' table for each included study using the 'Risk of bias' tool in Review Manager 5 (<a href="./references#CD012498-bbs2-0116" title="Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). </p> <p>We assessed the following for each study.</p> <p> <ul id="CD012498-list-0006"> <li> <p>Random sequence generation (checking for possible selection bias). We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, e.g. random number table; computer random number generator); unclear risk of bias (method used to generate sequence not clearly stated). We excluded studies using a non‐random process (e.g. odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Allocation concealment (checking for possible selection bias). The method used to conceal allocation to interventions prior to assignment determines whether intervention allocation could have been foreseen in advance of, or during, recruitment, or changed after assignment. We assessed the methods as: low risk of bias (e.g. telephone or central randomization; consecutively numbered, sealed, opaque envelopes); unclear risk of bias (method not clearly stated). We excluded studies that did not conceal allocation (e.g. open list). </p> </li> <li> <p>Blinding of participants and personnel (checking for possible performance bias). We assessed the methods used to blind study participants and personnel from knowledge of which intervention a participant received. We assessed methods as: low risk of bias (study states that it was blinded and describes the method used to achieve blinding, such as identical tablets matched in appearance or smell, or a double‐dummy technique); unclear risk of bias (study states that it was blinded but does not provide an adequate description of how this was achieved). We excluded studies that were not double‐blind. </p> </li> <li> <p>Blinding of outcome assessment (checking for possible detection bias). In this review, pain‐related outcomes were self assessed, so that the same considerations apply to detection bias as performance bias. </p> </li> <li> <p>Incomplete outcome data (checking for possible attrition bias due to the amount, nature, and handling of incomplete outcome data). We assessed the methods used to deal with incomplete data as: low risk (less than 10% of participants did not complete the study or used BOCF analysis or both); unclear risk of bias (used LOCF analysis); high risk of bias (used 'completer' analysis). </p> </li> <li> <p>Selective reporting (checking for reporting bias). We assessed whether primary and secondary outcome measures were prespecified and whether these were consistent with those reported. We assessed reporting of results as having low risk of bias (e.g. the study protocol was available and all of the study’s prespecified outcomes of interest in the review were reported in the prespecified way; the study protocol was not available but it is clear that published reports included all expected outcomes, including those that were prespecified); high risk of bias (e.g. not all of the study’s prespecified primary outcomes were reported; one or more primary outcomes were reported using measurements, analysis methods, or subsets of data that were not prespecified); or unclear risk of bias (information insufficient to permit judgement of ‘low risk’ or ‘high risk’). </p> </li> <li> <p>Size of study (checking for possible biases confounded by small size). We assessed studies as being at low risk of bias (200 participants or more per treatment arm); unclear risk of bias (50 to 199 participants per treatment arm); high risk of bias (fewer than 50 participants per treatment arm). </p> </li> </ul> </p> </section> <section id="CD012498-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>We used risk ratio (RR) to establish statistical difference, and number needed to treat for an additional beneficial outcome (NNTB) and pooled percentages as absolute measures of effect. </p> <p>We used the following terms to describe adverse outcomes in terms of harm or prevention of harm. </p> <p> <ul id="CD012498-list-0007"> <li> <p>When significantly fewer adverse outcomes occurred with treatment than with control (placebo or active), we used the term 'number needed to treat to prevent one additional harmful event' (NNTp). </p> </li> <li> <p>When significantly more adverse outcomes occurred with treatment compared with control (placebo or active), we used the term 'number needed to treat for an additional harmful outcome' (NNTH). </p> </li> </ul> </p> </section> <section id="CD012498-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>We accepted only randomization of the individual participant. When two or more active treatment arms were compared with a placebo arm within the same meta‐analysis, we avoided double‐counting of participants in the placebo arm by splitting the total number between the active arms. If we identified multiple‐dose studies, we used data for the most commonly used dose only. For cross‐over studies, we used data from the first treatment phase. </p> </section> <section id="CD012498-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>The only likely issue with missing data in these studies was from imputation using LOCF when a participant requests rescue medication. It has previously been shown that this does not affect results for up to six hours after taking study medication (<a href="./references#CD012498-bbs2-0108" title="MooreRA , EdwardsJE , McQuayHJ . Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain2005;116(3):322-31. [DOI: 10.1016/j.pain.2005.05.001]">Moore 2005</a>). Where large amounts of data were missing, we reported this in our review and assessed such results with caution. Where papers reported results using more than one method of imputation, we analyzed data using the primary method reported and performed sensitivity analysis by entering data from secondary methods. We also attempted to assess differences between intervention groups in reasons for missing data and how these differences might have biased results. </p> </section> <section id="CD012498-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity by visually examining forest plots and quantified it using the I² statistic. The I² statistic is a reliable and robust test to quantify heterogeneity, since it does not depend on the number of trials or on the between‐study variance. I² measures the extent of inconsistency among studies’ results, and can be interpreted as the proportion of total variation in study estimates that is due to heterogeneity rather than sampling error. An I² value of greater than 50% is considered to indicate substantial heterogeneity (<a href="./references#CD012498-bbs2-0077" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Deeks 2011</a>). </p> </section> <section id="CD012498-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>To assess the impact of reporting bias we considered the number of additional participants needed in studies with zero effect (relative benefit of one) required to change the NNTB for all statistically significant outcomes to an unacceptably high level (in this case the arbitrary NNTB of 10) (<a href="./references#CD012498-bbs2-0110" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA , editors(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [978-0-931092-69-5]">Moore 2008</a>). Where this number was less than 400 (equivalent to four studies with 100 participants per comparison, or 50 participants per group), we considered the results to be susceptible to publication bias and therefore unreliable (low‐quality evidence). </p> <p>We also attempted to mitigate the potential for publication bias by searching clinical trial websites, as noted above, and by contacting the manufacturers of parenteral diclofenac for an internal reference list of completed studies. </p> </section> <section id="CD012498-sec-0038"> <h4 class="title">Data synthesis</h4> <p>For efficacy analyses, we used the number of participants in each treatment group who were randomized, received medication, and provided at least one postbaseline assessment. For safety analyses, we used the number of participants randomized to each treatment group who took the study medication. </p> <p>For the primary outcome (participants achieving at least 50% pain relief over a four‐ to six‐hour period), if numbers were not reported directly, we converted the mean total pain relief (TOTPAR), or summed pain intensity difference (SPID), VAS TOTPAR, or VAS SPID (see Glossary: <a href="./appendices#CD012498-sec-0103">Appendix 1</a>) values for the active and placebo groups in each study to %maxTOTPAR or %maxSPID by division into the calculated maximum value (<a href="./references#CD012498-bbs2-0076" title="CooperSA . Single-dose analgesic studies: the upside and downside of assay sensitivity. In: MaxMB , PortenoyRK , LaskaEM , editors(s). The Design of Analgesic Clinical Trials. Advances in Pain Research and Therapy. Vol. 18. New York: Raven Press, 1991:117-24.">Cooper 1991</a>). We then calculated the proportion of participants in each treatment group who achieved at least 50%maxTOTPAR using verified equations (<a href="./references#CD012498-bbs2-0103" title="MooreA , McQuayH , GavaghanD . Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain1996;66(2-3):229-37. [DOI: 10.1016/0304-3959(96)03032-1]">Moore 1996</a>; <a href="./references#CD012498-bbs2-0104" title="MooreA , McQuayH , GavaghanD . Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data. Pain1997;69(1-2):127-30. [DOI: 10.1016/S0304-3959(96)03251-4]">Moore 1997a</a>; <a href="./references#CD012498-bbs2-0105" title="MooreA , MooreO , McQuayH , GavaghanD . Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales. Pain1997;69(3):311-5. [DOI: 10.1016/S0304-3959(96)03306-4]">Moore 1997b</a>), and converted these proportions into the number of participants achieving at least 50%maxTOTPAR by multiplying by the total number of participants in the treatment group. We used this information on the number of participants with at least 50%maxTOTPAR for active and placebo groups to calculate RR and NNTB. </p> <p>We accepted the following pain measures for the calculation of TOTPAR or SPID (in order of priority: see <a href="./appendices#CD012498-sec-0103">Appendix 1</a>). </p> <p> <ul id="CD012498-list-0008"> <li> <p>5‐point categorical pain relief scales with comparable wording to 'none,' 'slight,' 'moderate,' 'good,' and 'complete.' </p> </li> <li> <p>4‐point categorical pain intensity scales with comparable wording to 'none,' 'mild,' 'moderate,' and 'severe.' </p> </li> <li> <p>VAS for pain relief.</p> </li> <li> <p>VAS for pain intensity.</p> </li> </ul> </p> <p>If none of these measures was available, we planned to use the number of participants reporting 'very good or excellent' on a 5‐point categorical global scale with the wording 'poor,' 'fair,' 'good,' 'very good,' and 'excellent' for the number of participants achieving at least 50% pain relief (<a href="./references#CD012498-bbs2-0073" title="CollinsSL , EdwardsJ , MooreRA , SmithLA , McQuayHJ . Seeking a simple measure of analgesia for mega-trials: is a single global assessment good enough?Pain2001;91(1-2):189-94. [DOI: 10.1016/S0304-3959(00)00435-8]">Collins 2001</a>). </p> <p>For each treatment group, we extracted the number of participants using rescue medication and the number reporting treatment‐emergent AEs. </p> <p>If there were sufficient data, we calculated RR estimates with 95% confidence intervals (CIs) using the Mantel‐Haenszel method and a fixed‐effect model in Review Manager 5 (<a href="./references#CD012498-bbs2-0116" title="Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). We calculated NNTB and NNTH with 95% CIs using the pooled number of events and the method of Cook and Sackett (<a href="./references#CD012498-bbs2-0075" title="CookRJ , SackettDL . The number needed to treat: a clinically useful measure of treatment effect. BMJ1995;310(6977):452-4. [DOI: 10.1136/bmj.310.6977.452]">Cook 1995</a>). We assumed a statistically significant difference from control when the 95% CI of the RR did not include the number one. </p> </section> <section id="CD012498-sec-0039"> <h4 class="title">Quality of evidence</h4> <p>Two review authors (EM, MF) independently rated the quality of evidence for each outcome. We used the GRADE approach to assess the quality of evidence using GRADEpro GDT software (<a href="./references#CD012498-bbs2-0088" title="GRADEpro Guideline Development Tool [Software]. McMaster University (developed by Evidence Prime, Inc). Available from www.gradepro.org, 2015.">GRADEpro GDT 2015</a>), and the guidelines provided in Section 12.2 of the <i>Cochrane</i> <i>Handbook for Systematic Reviews of Interventions</i> (<a href="./appendices#CD012498-sec-0107">Appendix 5</a>) (<a href="./references#CD012498-bbs2-0093" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We reported our judgements on the quality of evidence in 'Summary of findings' tables. </p> <p>We paid particular attention to:</p> <p> <ul id="CD012498-list-0009"> <li> <p>inconsistency, where point estimates vary widely across studies or CIs of studies show minimal or no overlap (<a href="./references#CD012498-bbs2-0089" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 7. Rating the quality of evidence—inconsistency. Journal of Clinical Epidemiology2011;64(12):1294-302. [DOI: 10.1016/j.jclinepi.2011.03.017]">Guyatt 2011</a>); </p> </li> <li> <p>potential for publication bias, based on the amount of unpublished data required to make the result clinically irrelevant (<a href="./references#CD012498-bbs2-0110" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA , editors(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [978-0-931092-69-5]">Moore 2008</a>). </p> </li> </ul> </p> <p>In addition, there may be circumstances where the overall rating for a particular outcome needs to be adjusted as recommended by GRADE guidelines (<a href="./references#CD012498-bbs2-0090" title="GuyattG , OxmanAD , SultanS , BrozekJ , GlasziouP , Alonso-CoelloP , et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. Journal of Clinical Epidemiology2013;66(2):151-7. [DOI: 10.1016/j.jclinepi.2012.01.006]">Guyatt 2013a</a>). For example, if there were so few data that the results were highly susceptible to the random play of chance, or if studies use LOCF imputation in circumstances where there were substantial differences in AE withdrawals, one would have no confidence in the result, and would need to downgrade the quality of the evidence by three levels, to very low quality. In circumstances where there were no data reported for an outcome, we reported the level of evidence as very low quality (<a href="./references#CD012498-bbs2-0091" title="GuyattGH , OxmanAD , SantessoN , HelfandM , VistG , KunzR , et al. GRADE guidelines: 12. Preparing summary of findings tables—binary outcomes. Journal of Clinical Epidemiology2013;66(2):158-72. [DOI: 10.1016/j.jclinepi.2012.01.012]">Guyatt 2013b</a>). </p> <section id="CD012498-sec-0040"> <h5 class="title">'Summary of findings' table</h5> <p>We included 'Summary of findings' tables as set out in the Cochrane Pain, Palliative and Supportive Care Review Group author guide (<a href="./references#CD012498-bbs2-0115" title="Cochrane Pain, Palliative and Supportive Care Group (PaPaS) author and referee guidance. papas.cochrane.org/papas-documents (accessed 19 October 2014).">PaPaS 2012</a>), and recommended in Chapter 11 of the <i>Cochrane</i> <i>Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012498-bbs2-0093" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>), to present the main findings in a transparent and simple tabular format. In particular, we included key information concerning the quality of evidence (using GRADE), the magnitude of effect of the interventions examined, and the sum of available data on the outcomes of at least 50% of maximum pain relief over four to six hours; median (or mean) time to use of rescue medication; participants using rescue medication within four to six hours; participants with at least one AE; and participants with an SAE. </p> </section> </section> <section id="CD012498-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If there were sufficient data, we planned to analyze different doses separately. We also planned to analyze different formulations of parenteral diclofenac separately. We determined significant differences between different doses or formulations using the z test (<a href="./references#CD012498-bbs2-0122" title="TramèrMR , ReynoldsDJM , MooreRA , McQuayHJ . Impact of covert duplicate results on meta-analysis: a case study. BMJ1997;315(7109):635-40. [DOI: 10.1136/bmj.315.7109.635]">Tramèr 1997</a>), if appropriate. </p> </section> <section id="CD012498-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>For meta‐analyses with an I² score of greater than 50%, we re‐analyzed data using a random‐effects model. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012498-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012498-sec-0043"></div> <section id="CD012498-sec-0044"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD012498-sec-0119" title="">Characteristics of included studies</a>; <a href="./references#CD012498-sec-0120" title="">Characteristics of excluded studies</a>; <a href="./references#CD012498-sec-0121" title="">Characteristics of studies awaiting classification</a>; and <a href="./references#CD012498-sec-0122" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD012498-sec-0045"> <h4 class="title">Results of the search</h4> <p>Our literature search yielded 2616 references from CENTRAL, 2053 references from MEDLINE, and 1180 studies from Embase (a total of 3704 after de‐duplication). We reviewed the abstracts associated with these references and identified 64 potentially relevant studies, determining that the remaining references clearly did not meet our inclusion criteria. After full‐text review, we excluded 54 studies that did not meet our inclusion criteria. In addition, we were unable to find information regarding blinding for <a href="./references#CD012498-bbs2-0063" title="KumarPR , SoumyaS , KumarPS , KumarJS . The effectiveness of intravenous tramadol hydrochloride and diclofenac sodium as postoperative analgesia - a comparative study. International Journal of Pharmaceutical Sciences Review and Research2016;36(1):260-3. ">Kumar 2016</a>, despite attempting to contact the study authors, and have assigned this study to <a href="./references#CD012498-bbs1-0003" title="">Studies awaiting classification</a>. </p> <p>Our search of clinical trial websites yielded 22 ongoing or completed trials from ClinicalTrials.gov and 102 studies from the WHO ICTRP. From these, we found one potentially relevant ongoing study (<a href="#CD012498-fig-0001">Figure 1</a>) (<a href="./references#CD012498-bbs2-0064" title="NCT03493490. Neodolpasse infusion solution versus diclofenac 75 mg infusion in the treatment of postoperative pain after elective knee surgery. clinicaltrials.gov/ct2/show/NCT03493490 (first received 10 April 2018). ">NCT03493490</a>). </p> <div class="figure" id="CD012498-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012498-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012498-sec-0046"> <h4 class="title">Included studies</h4> <p>Eight studies fulfilled our inclusion criteria (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). </p> <p>One trial was conducted in Argentina (<a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>), one in Germany (<a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>), one in India (<a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>), three in the UK (<a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>), and two in the USA (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>). Total enrollment ranged from 39 to 353 participants, with the number of participants in each study receiving diclofenac ranging from 20 to 175, placebo 19 to 76, and another NSAID 29 to 82. Where reported, mean study population ages ranged from 24.5 years, in <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>, to 54.5 years, in <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>. The ages of participants generally reflected the type of surgical procedure, for example studies using a dental model enrolled younger participants. Four studies enrolled participants undergoing dental surgery (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>), with participants in <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a> and <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a> administered general anesthesia; two studies enrolled participants undergoing mixed minor/day surgeries (<a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>); and single studies assessed participants undergoing abdominal, <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>, and minor orthopedic, <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>, procedures. </p> <p>Where reported, all studies were funded in part or entirely by the manufacturers of one of the interventions. Two studies did not report funding (<a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). </p> <p>Study designs were similar: participants received one of the assigned interventions after reporting moderate to severe pain postoperatively, and outcomes such as pain relief, pain intensity difference, or time to use of rescue medication were assessed. The exception was the study by <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>, where participants had ready access to an opioid via patient‐controlled analgesia after receiving their assigned intervention, and opioid consumption was the primary outcome. </p> <p>Diclofenac doses varied among and within studies, ranging from 3.75 mg to 75 mg. The most commonly administered dose was 75 mg (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). Three studies assessed more than one dose (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>). </p> <p>The formulation of diclofenac also varied among and within studies. Three studies employed traditional formulations that required further dilution and slow infusion (over 20 to 30 minutes) (<a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). Five studies employed newer formulations that could be administered as an IV bolus without further dilution, in addition to or instead of traditional formulations (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>). Four of the five studies employed a formulation with the solubilizing agent HPβCD (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>), and one study employed a formulation that was only described as propylene glycol‐free (<a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>). Two of the studies directly compared the new formulation with a traditional formulation (<a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>). </p> <p>Comparator arms included participants administered placebo (<a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>), an alternative parenteral NSAID (<a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>), or both (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). Additionally, one study included two additional arms, administering doses of GR79236X (4 mcg/kg or 10 mcg/kg), an experimental adenosine agonist (<a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>). </p> </section> <section id="CD012498-sec-0047"> <h4 class="title">Studies awaiting classification</h4> <p>The manuscript for <a href="./references#CD012498-bbs2-0063" title="KumarPR , SoumyaS , KumarPS , KumarJS . The effectiveness of intravenous tramadol hydrochloride and diclofenac sodium as postoperative analgesia - a comparative study. International Journal of Pharmaceutical Sciences Review and Research2016;36(1):260-3. ">Kumar 2016</a> states that participants were blinded, but there is no mention of investigator blinding. This study compared a single postoperative dose of 75 mg of intravenous diclofenac with a single dose of 100 mg of intravenous tramadol in patients undergoing elective surgery. The authors reported that tramadol provided a longer duration of analgesia (undefined) versus diclofenac (5.54 ± 0.78 h versus 5.45 ± 0.54 h, P = 0.001), but that the time to onset of analgesia (undefined) was shorter in the diclofenac group (3.32 ± 0.90 min, P = 0.001) than in the tramadol group (4.84 ± 0.99 min). The mean pain score after 30 minutes was lower in the diclofenac group (P = 0.001) but at no other time points. Nausea, vomiting, and drowsiness occurred more frequently in participants receiving tramadol. </p> </section> <section id="CD012498-sec-0048"> <h4 class="title">Ongoing studies</h4> <p>One randomized controlled trial, found on ClinicalTrials.gov, is expected to be completed 31 January 2019 (<a href="./references#CD012498-bbs2-0064" title="NCT03493490. Neodolpasse infusion solution versus diclofenac 75 mg infusion in the treatment of postoperative pain after elective knee surgery. clinicaltrials.gov/ct2/show/NCT03493490 (first received 10 April 2018). ">NCT03493490</a>). It aims to enroll 72 participants post‐cruciate ligament repair or total knee replacement, and administer intravenous diclofenac, diclofenac plus orphenadrine, or placebo, and follow participants for 48 hours postoperatively. Its primary outcome is total opioid use via patient‐controlled analgesia in the first 24 hours after interventions are administered. </p> </section> <section id="CD012498-sec-0049"> <h4 class="title">Excluded studies</h4> <p>Fifty‐four studies did not meet all of our inclusion criteria (<a href="#CD012498-fig-0001">Figure 1</a>). Common reasons included wrong route of administration, pre‐ or intraoperative times of intervention administration, or multiple‐dose studies that did not report data separately for the first dose. Of the last, four publications reported data related to assessment of a novel formulation of diclofenac that employed the same solubilizing agent, HPβCD, as described in <a href="#CD012498-sec-0046">Included studies</a> (<a href="./references#CD012498-bbs2-0022" title="DanielsS , MelsonT , HamiltonDA , LangE , CarrDB . Analgesic efficacy and safety of a novel injectable formulation of diclofenac compared with intravenous ketorolac and placebo after orthopedic surgery: a multicenter, randomized, double-blinded, multiple-dose trial. Clinical Journal of Pain2013;29(8):655-63. ">Daniels 2013</a>; <a href="./references#CD012498-bbs2-0023" title="DanielsSE , GanTJ , HamiltonDA , SinglaN , LacouturePG , JohnsonO , et al. A pooled analysis evaluating renal safety in placebo- and active comparator-controlled Phase III trials of multiple-dose injectable HPβCD-diclofenac in subjects with acute postoperative pain. Pain Medicine2016;17(12):2378-88. ">Daniels 2016</a>; <a href="./references#CD012498-bbs2-0029" title="GanTJ , SinglaN , DanielsSE , LacouturePG , MinLH , ReyesCRD , et al. Cardiovascular safety of hydroxypropyl-beta-cyclodextrin-diclofenac in the management of acute postsurgical pain: a pooled analysis of 2 randomized, double-blind, placebo- and active comparator-controlled phase III clinical trials. Journal of Clinical Anesthesia2016;31:249-58. ">Gan 2016</a>; <a href="./references#CD012498-bbs2-0030" title="GanTJ , SinglaN , DanielsSE , HamiltonDA , LacouturePG , ReyesCRD , et al. Postoperative opioid sparing with injectable hydroxypropyl-beta-cyclodextrin-diclofenac: pooled analysis of data from two Phase III clinical trials. Journal of Pain Research2017;10:15-29. ">Gan 2017</a>). These publications merit mention as they describe studies that enrolled large numbers of participants and were similarly designed, enabling pooling of both efficacy and safety data. One of the studies included in the pooled analysis met our inclusion criteria (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>), and one did not, as it was a multiple‐dose study without separate data reported for the first dose (<a href="./references#CD012498-bbs2-0022" title="DanielsS , MelsonT , HamiltonDA , LangE , CarrDB . Analgesic efficacy and safety of a novel injectable formulation of diclofenac compared with intravenous ketorolac and placebo after orthopedic surgery: a multicenter, randomized, double-blinded, multiple-dose trial. Clinical Journal of Pain2013;29(8):655-63. ">Daniels 2013</a>). Analysis of 608 participants who received at least one dose of HPβCD diclofenac (interventions were administered either as a single dose or every 6 hours for up to 5 days) demonstrated a reduction in opioid requirements versus both placebo and ketorolac (P &lt; 0.005 for all comparisons) (<a href="./references#CD012498-bbs2-0030" title="GanTJ , SinglaN , DanielsSE , HamiltonDA , LacouturePG , ReyesCRD , et al. Postoperative opioid sparing with injectable hydroxypropyl-beta-cyclodextrin-diclofenac: pooled analysis of data from two Phase III clinical trials. Journal of Pain Research2017;10:15-29. ">Gan 2017</a>). In the same population, pooled analysis of safety events demonstrated that renal AEs (assessed by examining treatment‐emergent AEs and changes in postoperative blood urea nitrogen and serum creatinine levels) were rare in all treatment groups (<a href="./references#CD012498-bbs2-0023" title="DanielsSE , GanTJ , HamiltonDA , SinglaN , LacouturePG , JohnsonO , et al. A pooled analysis evaluating renal safety in placebo- and active comparator-controlled Phase III trials of multiple-dose injectable HPβCD-diclofenac in subjects with acute postoperative pain. Pain Medicine2016;17(12):2378-88. ">Daniels 2016</a>); cardiovascular events were also rare and comparable to placebo (<a href="./references#CD012498-bbs2-0029" title="GanTJ , SinglaN , DanielsSE , LacouturePG , MinLH , ReyesCRD , et al. Cardiovascular safety of hydroxypropyl-beta-cyclodextrin-diclofenac in the management of acute postsurgical pain: a pooled analysis of 2 randomized, double-blind, placebo- and active comparator-controlled phase III clinical trials. Journal of Clinical Anesthesia2016;31:249-58. ">Gan 2016</a>). </p> </section> </section> <section id="CD012498-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>Our findings are summarized in <a href="#CD012498-fig-0002">Figure 2</a> and <a href="#CD012498-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD012498-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012498-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012498-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012498-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012498-sec-0051"> <h4 class="title">Allocation</h4> <section id="CD012498-sec-0052"> <h5 class="title">Random sequence generation</h5> <p>All studies reported that they were randomized, and all but one described adequate methods of randomization, that is via computer‐generated numbers or a table of random numbers. <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a> did not describe how participants were randomized. </p> </section> <section id="CD012498-sec-0053"> <h5 class="title">Allocation concealment</h5> <p>Only one study described adequate allocation concealment (<a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>), via a central randomization process. In most of the remaining studies, allocation concealment was not mentioned. </p> </section> </section> <section id="CD012498-sec-0054"> <h4 class="title">Blinding</h4> <p>Three studies described adequate methods of blinding both investigators and participants (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>), with <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a> stating that the interventions were indistinguishable from each other. <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a> and <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a> described the methods used to ensure blinding in sufficient detail for us to believe that neither the investigator nor the study participant would have been able to discriminate interventions based on their appearance. We assessed four studies as having an unclear risk of bias, either because they did not describe methods of blinding in any way, or because their descriptions were inadequate for us to determine whether investigators or participants would have been able to distinguish interventions. Lastly, we assessed one study, <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>, as having a high risk of bias, as the different interventions were administered as either a bolus or short infusion, yet there was no mention of employing a double‐dummy technique. </p> </section> <section id="CD012498-sec-0055"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed the majority of studies as having an unclear risk of attrition bias, primarily because they did not describe how missing data were imputed. We assessed only two studies as having a low risk of bias (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>). In <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a><i>,</i> an intention‐to‐treat analysis was employed, and worst observation carried forward (WOCF) used to impute missing data for the primary endpoint. For <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>, the authors reported that all participants completed the study and reported data at each time point. </p> </section> <section id="CD012498-sec-0056"> <h4 class="title">Selective reporting</h4> <p>Only one study had a low risk of reporting bias (<a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>). While a protocol was not available for this study, all outcomes listed in its methods section were reported in full in the results section. We assessed one study as having a high risk of bias (<a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). The data for this study’s primary outcome were reported at several time points not mentioned in the methods section. Conversely, secondary outcomes described in the methods section were not reported in the results. We assessed the remaining studies as having unclear risk of bias, mostly due to incomplete reporting of secondary outcomes. </p> </section> <section id="CD012498-sec-0057"> <h4 class="title">Other potential sources of bias</h4> <p>The major threat to reliability was the small size of the studies. We assessed four studies as having a high risk of bias, as they had at least one arm that enrolled fewer than 50 participants (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). We assessed the remaining studies as having an unclear risk due to sample size. The highest number of participants in a single arm was 175, in <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a><i>.</i> </p> </section> </section> <section id="CD012498-sec-0058"> <h3 class="title" id="CD012498-sec-0058">Effects of interventions</h3> <p>See: <a href="./full#CD012498-tbl-0001"><b>Summary of findings 1</b> Intravenous diclofenac compared to placebo for acute postoperative pain in adults</a>; <a href="./full#CD012498-tbl-0002"><b>Summary of findings 2</b> Intravenous diclofenac compared to another NSAID for acute postoperative pain in adults</a> </p> <p>See <a href="./full#CD012498-tbl-0001">summary of findings Table 1</a> for outcomes for the main comparison, diclofenac versus placebo, and <a href="./full#CD012498-tbl-0002">summary of findings Table 2</a> for the comparison of diclofenac versus another NSAID. </p> <p>All eight included studies provided usable data for analysis. However, we did not use all data in meta‐analysis, either because there was only one study for a given outcome, or there were too few participants or events for a given outcome. We used none of the data from <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a> in any meta‐analysis, as the study compared two different formulations of IV diclofenac without including a placebo group. The only other study to compare two different formulations of diclofenac, <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>, did not appear to include the same formulations as <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>, therefore pooling of data between the two studies was not possible. </p> <section id="CD012498-sec-0059"> <h4 class="title">Proportion of participants achieving at least 50% postoperative pain relief over a four‐ to six‐hour period </h4> <p>No study reported numbers of participants achieving this outcome directly. We derived numbers, using the equations described earlier (<a href="#CD012498-sec-0038">Data synthesis</a>), from tables or figures. <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a> reported the proportion of participants with at least 30% pain relief; we used this as a surrogate value. </p> <section id="CD012498-sec-0060"> <h5 class="title">Diclofenac versus placebo</h5> <p>Three studies (277 participants) compared diclofenac 75 mg, <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>, or 50 mg, <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>, with placebo over four hours post‐administration of interventions. </p> <p> <ul id="CD012498-list-0010"> <li> <p>The proportion of participants with at least 50% pain relief with diclofenac was 65% (91/141, range 54% to 77%). </p> </li> <li> <p>The proportion of participants with at least 50% pain relief with placebo was 23% (31/136, range 6% to 38%). </p> </li> <li> <p>The relative benefit of treatment compared with placebo was 2.8 (95% confidence interval (CI) 2.0 to 4.0); the number needed to treat for an additional beneficial outcome (NNTB) for one additional participant to benefit compared with placebo was 2.4 (95% CI 1.9 to 3.1) (<a href="./references#CD012498-fig-0004" title="">Analysis 1.1</a>). </p> </li> </ul> </p> <p>Four studies (436 participants) compared diclofenac 75 mg, <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>, 50 mg, <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>, or 37.5 mg, <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>, with placebo over six hours post‐administration of interventions. </p> <p> <ul id="CD012498-list-0011"> <li> <p>The proportion of participants with at least 50% pain relief with diclofenac was 60% (135/225, range 50% to 70%). </p> </li> <li> <p>The proportion of participants with at least 50% pain relief with placebo was 34% (71/211, range 4% to 55%). </p> </li> <li> <p>The relative benefit of treatment compared with placebo was 1.8 (95% CI 1.4 to 2.2); the NNTB for one additional participant to benefit compared with placebo was 3.8 (95% CI 2.9 to 5.9) (<a href="./references#CD012498-fig-0005" title="">Analysis 1.2</a>). </p> </li> </ul> </p> <p>We assessed the quality of evidence for this outcome as low. We downgraded quality based on unclear risk of bias for several domains among the included studies and unexplained heterogeneity among studies. In addition, there was a low total number of participants in the analysis over four hours; however, we upgraded quality at this time point due to the large magnitude of effect, that is a risk ratio (RR) of 2.8. </p> </section> <section id="CD012498-sec-0061"> <h5 class="title">Diclofenac versus another NSAID</h5> <p>No studies provided data for the comparison of intravenous diclofenac with another NSAID over four hours. We therefore assessed the quality of evidence as very low. </p> <p>Three studies (360 participants) included comparisons of diclofenac 75 mg, <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>, or 37.5 mg, <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>, with another NSAID over six hours. </p> <p> <ul id="CD012498-list-0012"> <li> <p>The proportion of participants with at least 50% pain relief with diclofenac was 72% (132/184, range 59% to 89%). </p> </li> <li> <p>The proportion of participants with at least 50% pain relief with another NSAID was 77% (135/176, range 68% to 85%). </p> </li> <li> <p>The relative benefit of treatment compared with another NSAID was 0.9 (95% CI 0.8 to 1.1); the difference was not statistically significant (<a href="./references#CD012498-fig-0019" title="">Analysis 2.1</a>). </p> </li> </ul> </p> <p>We assessed the quality of evidence for this outcome as low at this time point, based on unclear risk of bias for several domains among the included studies and the low total number of participants analyzed. </p> </section> </section> <section id="CD012498-sec-0062"> <h4 class="title">Time to use of rescue medication</h4> <p>This outcome examined the time from taking study medication to use of rescue medication. A longer time to use of rescue medication indicates a longer duration of analgesia from the assigned intervention. Not all studies reported relevant data; of those that did, all reported median times to remedication, rather than means. </p> <section id="CD012498-sec-0063"> <h5 class="title">Diclofenac versus placebo</h5> <p>For the comparison of intravenous diclofenac versus placebo, the median time to use of rescue medication was 226 minutes for diclofenac and 80 minutes for placebo (5 studies, 542 participants) (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>). </p> <p>In almost all of these studies, time to rescue was statistically significantly longer in those participants assigned to diclofenac. <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a> reported that both IV diclofenac and IV ketorolac achieved statistically significantly longer times to rescue than placebo at all doses (P &lt; 0.05). Median time to rescue for those in the diclofenac 75 mg group was 6 hours 2 minutes versus 1 hour 9 minutes in the placebo group. <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a> reported median times to rescue for diclofenac of 2:24 hours (95% CI 1:50 to 4:23 hours, P = 0.0574 versus placebo) versus 2:07 hours (95% CI 1:15 to 2:40 hours) in the placebo group and 4:15 hours (95% CI 3:05 to not estimable, P = 0.0007 versus placebo) in the ketorolac group. <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a> reported that median times to rescue medication for those receiving HPβCD diclofenac and polyethylene glycol and benzyl alcohol (PG‐BA) diclofenac were 6 hours 26 minutes and 6 hours 32 minutes, respectively, compared with 1 hour 4 minutes for those receiving placebo. Both diclofenac formulations were superior to placebo (P &lt; 0.001) and were similar to each other. <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a> reported that participants receiving diclofenac IV 75 mg waited significantly (P &lt; 0.001) longer to use rescue medication than those assigned to placebo: median 62 minutes (95% CI 33 to 219 minutes) versus 50 minutes (95% CI 33 to 178 minutes). Lastly, <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a> reported that median times to rescue morphine were 363 minutes for participants receiving diclofenac 50 mg versus 62 minutes for those receiving placebo (P = 0.002). </p> <p>We judged the quality of evidence as low, based on risk of bias in the included studies and imprecision of findings. </p> </section> <section id="CD012498-sec-0064"> <h5 class="title">Diclofenac versus another NSAID</h5> <p>There were insufficient data for pooled analysis for comparisons of diclofenac with another NSAID. Only one study reported data (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>): the time to use of rescue medication was 144 minutes in those receiving 37.5 mg of IV diclofenac versus 255 minutes in those receiving 30 mg of IV ketorolac. </p> <p>We therefore judged the quality of evidence as very low.</p> </section> </section> <section id="CD012498-sec-0065"> <h4 class="title">Number of participants using rescue medication over a four‐ to six‐hour period</h4> <p>This outcome assessed the need for rescue analgesia in the period immediately after administering the assigned interventions. </p> <section id="CD012498-sec-0066"> <h5 class="title">Diclofenac versus placebo</h5> <p>Two studies (235 participants) included comparisons of diclofenac with placebo (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>). </p> <p> <ul id="CD012498-list-0013"> <li> <p>The proportion of participants using rescue medication with diclofenac was 48% (57/119, range 47% to 49%). </p> </li> <li> <p>The proportion of participants using rescue medication with placebo was 81% (94/116, range 80% to 82%). </p> </li> <li> <p>The relative benefit of treatment compared with placebo was 0.59 (95% CI 0.48 to 0.73); the number needed to treat to prevent one additional harmful event (NNTp) for one additional participant not to need to use rescue medication compared with placebo was 3.0 (95% CI 2.2 to 4.5) (<a href="./references#CD012498-fig-0006" title="">Analysis 1.3</a>). </p> </li> </ul> </p> <p>We judged the quality of evidence for this outcome as low, due to unclear risk of bias for several domains among the included studies and the low total number of participants analyzed. </p> </section> <section id="CD012498-sec-0067"> <h5 class="title">Diclofenac versus another NSAID</h5> <p>Only one study provided usable data for diclofenac versus another NSAID (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>). </p> <p> <ul id="CD012498-list-0014"> <li> <p>The proportion of participants using rescue medication with diclofenac 75 mg was 47% (24/51). </p> </li> <li> <p>The proportion of participants using rescue medication with ketorolac 30 mg was 26% (12/47). </p> </li> <li> <p>The relative risk of diclofenac compared with ketorolac was 1.84 (95% CI 1.04 to 3.25); the NNTp for one additional participant not to need to use rescue medication was 4.5 (95% CI 2.5 to 33) for ketorolac versus diclofenac (<a href="./references#CD012498-fig-0020" title="">Analysis 2.2</a>). </p> </li> </ul> </p> <p>We judged the quality of evidence for this outcome as very low, due to unclear risk of bias for several domains among the included studies and the low total number of participants analyzed. We assessed the low total number of participants analyzed as being a contributing factor to imprecision. In addition, we assessed the findings for this outcome to be at high risk of publication bias. Data from additional unpublished studies demonstrating zero effect with only 120 participants would be sufficient to render the NNTp more than 10, that is clinically insignificant. </p> </section> </section> <section id="CD012498-sec-0068"> <h4 class="title">Withdrawals due to lack of efficacy, adverse events, and for any cause</h4> <p>Numbers of participants withdrawing were generally low, and reasons for withdrawal were inconsistently reported. We therefore judged the quality of evidence for these outcomes to be very low. </p> <section id="CD012498-sec-0069"> <h5 class="title">Diclofenac versus placebo</h5> <p> <ul id="CD012498-list-0015"> <li> <p>The proportion of participants withdrawing due to lack of efficacy was 6% (8/140) with diclofenac versus 5% (7/128) with placebo (<a href="./references#CD012498-fig-0007" title="">Analysis 1.4</a>; participants = 268; studies = 2). </p> </li> <li> <p>The proportion of participants withdrawing due to AEs was 2% (4/211) with diclofenac versus 0% (0/198) with placebo (<a href="./references#CD012498-fig-0008" title="">Analysis 1.5</a>; participants = 409; studies = 4). The four withdrawals all occurred in one study (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>), and only one was suspected as being treatment‐related (peripheral edema). </p> </li> <li> <p>The proportion of participants withdrawing for any cause was 11% (21/191) with diclofenac versus 17% (30/179) with placebo (<a href="./references#CD012498-fig-0009" title="">Analysis 1.6</a>; participants = 370; studies = 4). The majority of withdrawals occurred in one study (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>), primarily due to participants' requests. </p> </li> </ul> </p> </section> <section id="CD012498-sec-0070"> <h5 class="title">Diclofenac versus another NSAID</h5> <p> <ul id="CD012498-list-0016"> <li> <p>The proportion of participants withdrawing due to lack of efficacy was 9% (8/87) with diclofenac versus 7% (6/82) with another NSAID (<a href="./references#CD012498-fig-0021" title="">Analysis 2.3</a>; participants = 169; studies = 1) (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>). </p> </li> <li> <p>The proportion of participants withdrawing due to AEs was 3% (4/138) with diclofenac versus 2% (2/129) with another NSAID (<a href="./references#CD012498-fig-0022" title="">Analysis 2.4</a>; participants = 267; studies = 2). </p> </li> <li> <p>The proportion of participants withdrawing for any cause was 18% (21/118) with diclofenac versus 15% (17/111) with another NSAID (<a href="./references#CD012498-fig-0023" title="">Analysis 2.5</a>; participants = 229; studies = 2). The vast majority of withdrawals occurred in one study (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>), primarily due to participants' requests. </p> </li> </ul> </p> </section> </section> <section id="CD012498-sec-0071"> <h4 class="title">Participants experiencing any adverse event</h4> <p>Not all studies reported the number of participants experiencing any AE. The time over which AEs were measured varied. In one multiple‐dose study (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>), AEs were measured through the end of the study (five to nine days after baseline observations). </p> <section id="CD012498-sec-0072"> <h5 class="title">Diclofenac versus placebo</h5> <p>Two studies (296 participants) included comparisons of diclofenac with placebo (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>). </p> <p> <ul id="CD012498-list-0017"> <li> <p>The proportion of participants reporting an AE with diclofenac was 71% (110/155).</p> </li> <li> <p>The proportion of participants reporting an AE with placebo was 71% (100/141).</p> </li> <li> <p>The relative benefit of treatment compared with placebo was 0.99 (95% CI 0.86 to 1.14); the NNTH was not calculated (<a href="./references#CD012498-fig-0010" title="">Analysis 1.7</a>). </p> </li> </ul> </p> </section> <section id="CD012498-sec-0073"> <h5 class="title">Diclofenac versus another NSAID</h5> <p>Two studies reported the number of participants experiencing any AE (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>). Seventy‐four of 135 participants (55%) receiving diclofenac experienced an AE versus 75 of 130 (58%) receiving ketorolac (<a href="./references#CD012498-fig-0024" title="">Analysis 2.6</a>). </p> <p>We assessed the quality of evidence for both comparisons as low, based on unclear risk of bias in several domains for the included studies, and the low total number of participants for each analysis. </p> </section> </section> <section id="CD012498-sec-0074"> <h4 class="title">Participants experiencing any serious adverse event</h4> <p>Serious AEs were rare overall, preventing meta‐analysis (<a href="./references#CD012498-fig-0011" title="">Analysis 1.8</a>; <a href="./references#CD012498-fig-0025" title="">Analysis 2.7</a>). We assessed the quality of evidence for this outcome as low, based on the very low event rates and unclear risk of bias for several domains in the included studies. </p> <p>Seven studies reported incidence of SAEs (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). Only one participant administered diclofenac suffered an SAE (<a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). The participant experienced a reduction in oxygen saturation to less than 90% at seven hours postdosing. However, in this study participants had free access to opioids via patient‐controlled analgesia. Respiratory depression is a recognized side effect of opioid use. One participant receiving placebo experienced an SAE (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>), appendicitis, which was deemed unrelated to therapy. One participant administered ketorolac experienced an abdominal hematoma (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>), which was thought to possibly be treatment‐related. </p> </section> <section id="CD012498-sec-0075"> <h4 class="title">Specific adverse events</h4> <p>Methods of assessment and the reporting of specific AEs were inconsistent across studies, as was the time over which the information was collected. Our AEs of interest (renal dysfunction, cardiovascular events, bleeding, and thrombophlebitis) occurred infrequently in all groups, therefore data were insufficient for meta‐analysis. As with our analysis of SAEs, we assessed the quality of evidence to be low. </p> <section id="CD012498-sec-0076"> <h5 class="title">Renal dysfunction</h5> <p>Only one incidence of renal dysfunction was reported (<a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>). This occurred in a participant receiving placebo and was defined as an increase in serum creatinine (data not specified) (<a href="./references#CD012498-fig-0012" title="">Analysis 1.9</a>; <a href="./references#CD012498-fig-0026" title="">Analysis 2.8</a>). </p> </section> <section id="CD012498-sec-0077"> <h5 class="title">Cardiovascular events</h5> <p>In the three studies that reported cardiovascular events (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>), 2% (4/188) of participants receiving diclofenac experienced an event versus 5% (7/128) of participants receiving placebo and 4% (5/130) of those receiving another NSAID. In the one study in which cardiovascular events occurred (not defined), none were considered to be treatment‐related (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>). Comparisons between diclofenac and placebo or another NSAID were not statistically different (<a href="./references#CD012498-fig-0013" title="">Analysis 1.10</a>; <a href="./references#CD012498-fig-0027" title="">Analysis 2.9</a>). </p> </section> <section id="CD012498-sec-0078"> <h5 class="title">Bleeding</h5> <p>In the two studies that compared diclofenac with placebo (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>), 4% of participants (6/140) receiving diclofenac experienced clinically significant bleeding versus 5% (6/128) of those receiving placebo (<a href="./references#CD012498-fig-0014" title="">Analysis 1.11</a>). </p> <p>In the two studies comparing diclofenac with another NSAID (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>), 4% of participants (5/135) receiving diclofenac experienced clinically significant bleeding versus 4% (5/130) of those receiving another NSAID (<a href="./references#CD012498-fig-0028" title="">Analysis 2.10</a>). </p> </section> <section id="CD012498-sec-0079"> <h5 class="title">Thrombophlebitis</h5> <p>In those studies that assessed thrombophlebitis, the majority employed a six‐point scale (grade 0 = "no reaction" to grade 5 = "thrombosis with overt infection") and defined events as occurring in participants with a score of more than 1. </p> <p>In the three studies that compared diclofenac with placebo (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>), 3% of participants (6/191) receiving diclofenac experienced thrombophlebitis versus 6% (10/179) of those receiving placebo (<a href="./references#CD012498-fig-0015" title="">Analysis 1.12</a>). </p> <p>In the three studies comparing diclofenac with another NSAID (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>), 2% of participants (3/186) receiving diclofenac experienced an event versus 3% (6/181) of those receiving another NSAID (<a href="./references#CD012498-fig-0029" title="">Analysis 2.11</a>). </p> </section> <section id="CD012498-sec-0080"> <h5 class="title">Opioid‐related events</h5> <p>We also performed a post hoc analysis of AEs that might be considered to be related to opioid use. There were insufficient data for any pooled analysis when comparing diclofenac with another NSAID. There were sufficient data for meta‐analysis for two outcomes, nausea and vomiting, when comparing diclofenac with placebo. </p> <p>Three studies (401 participants) compared rates of nausea with diclofenac versus placebo (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>). </p> <p> <ul id="CD012498-list-0018"> <li> <p>The proportion of participants reporting nausea with diclofenac was 17% (36/208, range 2% to 25%). </p> </li> <li> <p>The proportion of participants reporting nausea with placebo was 25% (48/193, range 8% to 38%). </p> </li> <li> <p>The relative benefit of treatment compared with placebo was 0.68 (95% CI 0.47 to 0.99); the NNTp for one additional participant not to report nausea compared with placebo was 12.5 (95% CI 6.3 to &gt; 100) (<a href="./references#CD012498-fig-0016" title="">Analysis 1.13</a>). </p> </li> </ul> </p> <p>The same three studies (401 participants) compared rates of vomiting with diclofenac versus placebo. </p> <p> <ul id="CD012498-list-0019"> <li> <p>The proportion of participants experiencing an incidence of vomiting with diclofenac was 6% (13/208, range 0% to 12%). </p> </li> <li> <p>The proportion of participants experiencing an incidence of vomiting with placebo was 13% (25/193, range 6% to 17%). </p> </li> <li> <p>The relative benefit of treatment compared with placebo was 0.49 (95% CI 0.26 to 0.91); the NNTp for one additional participant not to experience vomiting compared with placebo was 14.3 (95% CI 7.7 to 100) (<a href="./references#CD012498-fig-0017" title="">Analysis 1.14</a>). </p> </li> </ul> </p> </section> </section> <section id="CD012498-sec-0081"> <h4 class="title">Subgroup analysis, sensitivity analysis, and investigation of heterogeneity</h4> <p>Where there were sufficient data, we analyzed the effect of different doses separately. Doses assessed within and among studies doses ranged from 3.75 mg to 75 mg. The most commonly administered dose was 75 mg (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0003" title="GarciaDC , EspinosaJD , MartiML . Analgesic efficacy of both lisine clonixinate and diclofenac for the postsurgical pain during ambulatory surgery [Eficacia analgesica del clonixinato de lisina y del diclofenac en dolor postoperatorio de cirugia ambulatoria]. Prensa Medica Argentina1997;84(10):1061-5. ">Garcia 1997</a>; <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>; <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>; <a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). We used the highest dose assessed in each study for our initial analysis. There were sufficient data for a dose‐effect analysis for our primary outcome for only one alternative dose, 18.75 mg (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>; <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>). We compared participants receiving 18.75 mg with placebo, another NSAID, and with the higher dose of diclofenac for the number of participants with at least 50% pain relief at six hours. </p> <p> <ul id="CD012498-list-0020"> <li> <p>For the two included studies, the high‐dose analysis (75 mg in <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a> and 37.5 mg in <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>) demonstrated a relative benefit of treatment compared with placebo of 1.9 (95% CI 1.4 to 2.4), whereas for the group receiving 18.75 mg of diclofenac, the relative benefit versus placebo was 1.6 (95% CI 1.2 to 2.1) (<a href="./references#CD012498-fig-0018" title="">Analysis 1.15</a>). </p> </li> <li> <p>In comparison to another NSAID, the high‐dose analysis demonstrated a relative benefit of 0.9 (95% CI 0.8 to 1.1), whereas for the group receiving 18.75 mg, the relative benefit was 0.78 (95% CI 0.65 to 0.93) (<a href="./references#CD012498-fig-0030" title="">Analysis 2.12</a>). </p> </li> <li> <p>For the direct comparison of high‐dose versus low‐dose diclofenac (18.75 mg), the proportion of participants with at least 50% pain relief was 66% (90/137) in the high‐dose arm versus 57% (77/135) in the low‐dose arm. The relative benefit of high‐dose versus low‐dose diclofenac was 1.2 (95% CI 1.0 to 1.4), that is the difference was not statistically significant (<a href="./references#CD012498-fig-0031" title="">Analysis 3.1</a>). </p> </li> </ul> </p> <p>We also planned to analyze different formulations of parenteral diclofenac separately. There were insufficient data for subgroup meta‐analysis. Two studies performed head‐to‐head analyses of different formulations. <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a> compared a novel formulation of diclofenac (Dyloject) that was administered as a small‐volume IV bolus, with the traditional formulation (Voltarol), which was infused over 30 minutes. For our primary outcome, the proportion of participants with at least 50% pain relief over four hours was 77% (41/53) for participants receiving the new formulation versus 68% (34/50) for those receiving the traditional formulation. In addition, 6% (3/53) of participants experienced thrombophlebitis (as defined above) in the bolus group versus 12% (6/50) of those receiving the longer infusion. Similarly, <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a> compared a reduced‐volume propylene‐glycol‐free formulation (Dynapar AQ), administered as an IV bolus over 5 to 60 seconds, with the traditional formulation (Voveran), diluted to 100 mL to 500 mL, buffered with sodium bicarbonate, and infused over 30 minutes. For our primary outcome, the proportion of participants with at least 50% pain relief over four hours was 69% (121/175) for participants receiving the new formulation versus 63% (110/175) for those receiving the traditional formulation. In addition, only 2 of 175 participants (1%) experienced thrombophlebitis in the bolus group versus 27% (47/175) in the group receiving the longer infusion. </p> <p>For meta‐analyses with an I² score of greater than 50%, we re‐analyzed the data using a random‐effects model. Two analyses that had previously demonstrated superiority of diclofenac over placebo were now no longer statistically significant (<a href="./references#CD012498-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD012498-fig-0018" title="">Analysis 1.15</a>). For <a href="./references#CD012498-fig-0004" title="">Analysis 1.1</a>, the number of participants with at least 50% pain relief at six hours, one of the studies, <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>, had a higher rate of events in the placebo group than the other two studies (<a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a>). The reasons for this higher rate in the placebo group are unclear. All three studies employed a dental model, that is third molar extraction. <a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a> and <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a> both administered 75 mg of diclofenac to the active group, whereas <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a> administered 50 mg. Residual effects of general anesthesia may account for higher rates in placebo groups, but participants in <a href="./references#CD012498-bbs2-0007" title="SneydJR , LangtonJA , AllanLG , PeacockJE , RowbothamDJ . Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. British Journal of Anaesthesia2007;98(5):672-6. ">Sneyd 2007</a> also received general anesthesia and a higher intraoperative opioid dose than <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>. Participant withdrawal criteria and imputation of missing data may have contributed to higher placebo rates. In <a href="./references#CD012498-bbs2-0006" title="SeymourRA , MooreU , HawkesfordJ , CoulthardP , Jackson-LeechD , ThomasD , et al. An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. European Journal of Clinical Pharmacology2000;56(6-7):447-52. ">Seymour 2000</a>, participants using rescue analgesia during the first hour were excluded from the study; however, it is unclear how many participants were excluded for this reason. For those taking remedication after one hour, LOCF was employed. For <a href="./references#CD012498-fig-0018" title="">Analysis 1.15</a>, which assessed the number of participants with at least 50% pain relief for the lower diclofenac dose of 18.75 mg, we included two studies: <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a> and <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>. <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a> had a much higher event rate in the placebo group than <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a>. This may be due to the different surgical models (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a> abdominal, <a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a> dental) or the residual effects of general anesthesia in <a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a> (<a href="./references#CD012498-bbs2-0001" title="ChristensenK , DanielsS , BandyD , ErnstCC , HamiltonDA , MermelsteinFH , et al. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesthesia Progress2011;58(2):73-81. ">Christensen 2011</a> employed local anesthesia), or both. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012498-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012498-sec-0082"></div> <section id="CD012498-sec-0083"> <h3 class="title" id="CD012498-sec-0083">Summary of main results</h3> <p>We found eight studies for inclusion in this review. Study designs were similar, in that most required participants to report moderate to severe pain postoperatively before being assigned to one of the planned intervention groups. Most were single‐dose studies that measured pain relief or pain intensity difference after an intervention was administered. Doses of diclofenac varied among studies, although the most commonly employed dose was 75 mg, that is the dose used in clinical practice. Some studies compared multiple doses. In addition, different formulations of parenteral diclofenac were employed in some studies, with newer formulations being produced with the aim of ease of administration, faster onset of action, and a lower incidence of thrombophlebitis than traditional formulations. Despite the similarity of study designs, considerable heterogeneity existed in many of the pooled analyses. There were no obvious explanations for the differences in event rates among studies. There were insufficient data to draw conclusions regarding differences in efficacy or safety based on dose or formulation. The results of the studies available for parenteral diclofenac suggest that it is superior to placebo and similar to other NSAIDs, with respect to analgesic effect, and that it has a similar safety profile to both. However, the quality of evidence across outcomes was generally low, primarily due to the low number of participants and events and unexplained heterogeneity among studies. </p> <section id="CD012498-sec-0084"> <h4 class="title">Efficacy</h4> <p>Analysis of our primary outcome, participants achieving at least 50% maximum pain relief, demonstrated that diclofenac was superior to placebo and similar to other NSAIDs. Analysis of low‐dose versus higher‐dose diclofenac did not demonstrate a dose‐response effect, although this was based on data from only two studies. The relative benefit of diclofenac compared with placebo over four hours was 2.8 (95% CI 2.0 to 4.0). Almost three times as many participants achieved at least 50% pain relief in the diclofenac group compared with those receiving placebo. The NNTB for one additional participant to benefit compared with placebo was 2.4 (95% CI 1.9 to 3.1), which indirectly compares favorably with oral analgesics used in the same setting (<a href="./references#CD012498-bbs2-0112" title="MooreRA , DerryS , McQuayHJ , WiffenPJ . Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2011, Issue 9. Art. No: CD008659. [DOI: 10.1002/14651858.CD008659.pub2]">Moore 2011b</a>), and similarly to 20 mg of parenteral parecoxib, the only other parenteral NSAID to be analyzed in a Cochrane Review of postoperative pain (<a href="./references#CD012498-bbs2-0096" title="LloydR , DerryS , MooreRA , McQuayHJ . Intravenous or intramuscular parecoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2009, Issue 2. Art. No: CD004771. [DOI: 10.1002/14651858.CD004771]">Lloyd 2009</a>). Of note, parecoxib is not available in the USA. The relative benefit at six hours was slightly less (RR 1.8, 95% CI 1.4 to 2.2), suggesting that the analgesic effect of diclofenac starts to decline after four hours. Parenteral diclofenac also demonstrated lower (i.e. superior) NNTBs at four and six hours versus those found in a Cochrane Review of parenteral formulations of paracetamol (acetaminophen) for postoperative pain, where NNTBs were 5 and 6 at four and six hours, respectively (<a href="./references#CD012498-bbs2-0099" title="McNicolED , FergusonMC , HaroutounianS , CarrDB , SchumannR . Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain. Cochrane Database of Systematic Reviews2016, Issue 5. Art. No: CD007126. [DOI: 10.1002/14651858.CD007126]">McNicol 2016</a>). Direct comparison of diclofenac with other NSAIDs within this review suggested similar efficacy (RR 0.94, 95% CI 0.83 to 1.06), but subgroup analysis where a lower dose of 18.75 mg of diclofenac was compared with parenteral ketorolac demonstrated statistical inferiority (RR 0.78, 95% CI 0.65 to 0.93), suggesting that lower doses may be less effective. </p> <p>For secondary efficacy outcomes, median time to remedication was longer, and the number of participants requesting rescue analgesia was lower (NNTp 3.0, 95% CI 2.2 to 4.5) in those receiving diclofenac versus those receiving placebo. There were insufficient data to analyze these outcomes in head‐to‐head comparisons with another NSAID. Lastly, there were insufficient data to perform pooled analyses of the number of participants withdrawing from a trial due to lack of efficacy. </p> </section> <section id="CD012498-sec-0085"> <h4 class="title">Safety</h4> <p>Total AE rates were very similar to those with placebo and with other NSAIDs. There was a lack of data for our planned analyses of specific AEs associated with NSAID use, that is renal dysfunction, cardiovascular events, and bleeding, as well as for thrombophlebitis, a recognized issue with parenteral diclofenac use. This no doubt reflects the relative infrequency with which these events occur, particularly in studies of short duration. Limited data from two studies that compared rates of thrombophlebitis with newer formulations of diclofenac versus traditional formulations suggest that rates are lower with newer formulations (<a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>; <a href="./references#CD012498-bbs2-0005" title="MarooSKH , KakarPN , VarshneyAK , SubnisBM , BograJA , MohiteSN , et al. Dynapar AQ iv bolus injection for postoperative pain. International Journal of Pharmaceutical Sciences Review and Research2013;4(12):4729-35. ">Maroo 2013</a>). Data from the one study that compared rates of bleeding with diclofenac versus ketorolac did not show a difference, therefore the hypothesis that the balanced COX‐1/COX‐2 profile of diclofenac results in a reduced rate of bleeding versus the COX‐1 specific ketorolac was not confirmed in this review (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>). </p> <p>We performed a post hoc analysis of AEs associated with opioid use to assess whether a reduction in requirement for rescue analgesia (typically an opioid) in turn resulted in a reduction in the rate of occurrence of these events. There were statistically significant reductions in the rates of nausea and vomiting when diclofenac was compared to placebo, but insufficient data for any other comparison. This may be due to studies not actively assessing opioid‐induced side effects. </p> <p>Only one participant experienced an SAE, respiratory depression, when administered diclofenac, and this was unlikely to be related to the intervention (<a href="./references#CD012498-bbs2-0008" title="SteffenP , WiedemannS , GeorgieffM , HahnelJ , TreiberH , SeelingW . Combined intravenous administration of diclofenac and apazone for postoperative analgesia. A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations [Kombinierte intravenose gabe von diclofenac und azapropazon zur postoperativen analgesie. Eine randomisierte doppelblindstudie an 112 unfallchirurgischen patienten mittels der intravenosen on-demand-analgesie.]. Schmerz (Berlin, Germany)1994;8:235-42. ">Steffen 1994</a>). </p> <p>Lastly, withdrawals due to AEs were vary rare in all groups, again reflecting the acute nature of such studies. </p> </section> </section> <section id="CD012498-sec-0086"> <h3 class="title" id="CD012498-sec-0086">Overall completeness and applicability of evidence</h3> <p>The primary limitation of our review was the small number of studies, participants, and events for most analyses. The limited data prevented us from interpreting safety data in particular with any confidence. </p> <p>Included studies reported data from comparisons of diclofenac with both placebo and with active controls that are routinely used to treat postoperative pain. The studies covered a range of commonly performed surgeries, but no studies were performed in patients undergoing major or cardiovascular surgeries. The lack of studies in major surgeries may explain the lack of data with respect to reduction in opioid consumption and opioid‐induced AEs, as opioids would be a major component of the postoperative regimen in more invasive procedures. The lack of studies in cardiovascular surgeries is perhaps not surprising given guidelines from regulatory organizations that recommend avoiding NSAIDs in patients undergoing coronary artery bypass surgery (<a href="./references#CD012498-bbs2-0095" title="JenkinsJK , SeligmanPJ . Memorandum: analysis and recommendations for agency action regarding non-steroidal anti-inflammatory drugs and cardiovascular risk. www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm106201.pdf (accessed 7 October 2017).">Jenkins 2005</a>). </p> <p>The mean age of participants across studies indicates that few elderly participants were assessed. The lack of data is unfortunate, given evidence suggesting AE rates related to acute NSAID use are notably higher in this population (<a href="./references#CD012498-bbs2-0118" title="StromBL , BerlinJA , KinmanJL , SpitzPW , HennessyS , FeldmanH , et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: a postmarketing surveillance study. JAMA1996;275(5):376-82.">Strom 1996</a>). </p> </section> <section id="CD012498-sec-0087"> <h3 class="title" id="CD012498-sec-0087">Quality of the evidence</h3> <p>When assessing the quality of findings using GRADE, we generally ranked the quality of the evidence as low across all efficacy and safety outcomes, as shown in <a href="./full#CD012498-tbl-0001">summary of findings Table 1</a> and <a href="./full#CD012498-tbl-0002">summary of findings Table 2</a>. 'Low quality' means that our confidence in the effect estimate is limited, and the true effect may be substantially different from the estimate of the effect. Many individual studies had unclear risk of bias for issues such as incomplete outcome data, selective reporting, and small size, and none of the trials was unequivocally at low risk of bias for all criteria. The lack of clarity regarding many of the risks of bias may be due to the reporting standards of journals rather than any fundamental flaws in the methodology of the studies, in which case we would assess the quality of evidence as being moderate. For the outcomes for which we were able to perform pooled analysis, we further downgraded the quality of evidence due to issues with imprecision, unexplained heterogeneity between studies, and low overall numbers of participants and events. </p> </section> <section id="CD012498-sec-0088"> <h3 class="title" id="CD012498-sec-0088">Potential biases in the review process</h3> <p>We attempted to minimize the potential for publication bias related to unpublished or unidentified studies by assessing clinical trial registries and multiple databases, respectively. In addition, we assessed the impact publication bias may have on our findings. </p> <p>For analysis of our primary outcome of pain relief, we used the number of participants with 30% pain relief, rather than at least 50% pain relief, for one study (<a href="./references#CD012498-fig-0005" title="">Analysis 1.2</a>; <a href="./references#CD012498-fig-0019" title="">Analysis 2.1</a>) (<a href="./references#CD012498-bbs2-0002" title="GanTJ , DanielsSE , SinglaN , HamiltonDA , CarrDB . A novel injectable formulation of diclofenac compared with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multicenter, double-blind, randomized, multiple-dose study. Anesthesia and Analgesia2012;115(5):1212-20. ">Gan 2012</a>), as these were the only data available for this study. Not surprisingly, more participants achieved at least 30% pain relief in this study than the proportion of those achieving at least 50% in the other studies included in these analyses. However, NNTBs for 30% and 50% pain relief have been shown to be similar over six hours when effective analgesics are compared with placebo (<a href="./references#CD012498-bbs2-0106" title="MooreRA , McQuayHJ . Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain1997;69:287-94.">Moore 1997c</a>; <a href="./references#CD012498-bbs2-0108" title="MooreRA , EdwardsJE , McQuayHJ . Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain2005;116(3):322-31. [DOI: 10.1016/j.pain.2005.05.001]">Moore 2005</a>), given that event rates tend to change proportionally in both groups when different cutpoints of pain relief are measured. </p> <p>We did not assess time to onset of analgesia as an efficacy outcome. One study of a newer diclofenac formulation demonstrated a faster onset of analgesia with this formulation than with the traditional formulation that required slow infusion (<a href="./references#CD012498-bbs2-0004" title="LeesonRM , HarrisonS , ErnstCC , HamiltonDA , MermelsteinFH , GawareckiDG , et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Regional Anesthesia and Pain Medicine2007;32(4):303-10. ">Leeson 2007</a>). This may be important to patients. </p> <p>We are not aware of any other potential biases.</p> </section> <section id="CD012498-sec-0089"> <h3 class="title" id="CD012498-sec-0089">Agreements and disagreements with other studies or reviews</h3> <p>There are not, to our knowledge, any other systematic reviews of IV diclofenac for postoperative pain. <a href="./references#CD012498-bbs2-0082" title="DerryS , WiffenPJ , MooreRA . Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database of Systematic Reviews2015, Issue 7. Art. No: CD004768. [DOI: 10.1002/14651858.CD004768]">Derry 2015</a> conducted a systematic review and meta‐analysis of single doses of various formulations of oral diclofenac for postoperative pain, assessing similar outcomes to our review. They found similar results for efficacy, including an NNTB of 2.1 (95% CI 1.9 to 2.5) for diclofenac potassium 50 mg for the proportion of participants with at least 50% of maximum pain relief over four to six hours postinterventions. Unlike our review, the majority of included studies employed a dental model. It has been suggested that NSAIDs appear to be more effective in dental models than in other postoperative models, although this has not been confirmed (<a href="./references#CD012498-bbs2-0067" title="BardenJ , EdwardsJE , McQuayHJ , MooreRA . Pain and analgesic response after third molar extraction and other postsurgical pain. Pain2004;107:86-90.">Barden 2004</a>). However, four of the studies used in our analyses of pain relief versus placebo also employed the dental model, suggesting that oral and IV diclofenac may have similar efficacy, although this does not account for situations in which the enteral route is not available. Safety analyses also had similar findings, that is events occurred too infrequently to enable any firm conclusions to be made about either formulation's side effect profile. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012498-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012498-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012498-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012498-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 1: Number of participants with at least 50% pain relief at 4 hours" data-id="CD012498-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 1: Number of participants with at least 50% pain relief at 4 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 2: Number of participants with at least 50% pain relief at 6 hours" data-id="CD012498-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 2: Number of participants with at least 50% pain relief at 6 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 3: Number of participants using rescue medication over 4 to 6 hours postinterventions" data-id="CD012498-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 3: Number of participants using rescue medication over 4 to 6 hours postinterventions </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 4: Number of participants withdrawing due to lack of efficacy" data-id="CD012498-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 4: Number of participants withdrawing due to lack of efficacy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 5: Number of participants withdrawing due to adverse events" data-id="CD012498-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 5: Number of participants withdrawing due to adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 6: Number of participants withdrawing for any cause" data-id="CD012498-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 6: Number of participants withdrawing for any cause </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 7: Number of participants reporting any adverse event" data-id="CD012498-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 7: Number of participants reporting any adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 8: Number of participants experiencing a serious adverse event" data-id="CD012498-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 8: Number of participants experiencing a serious adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 9: Number of participants experiencing renal dysfunction" data-id="CD012498-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 9: Number of participants experiencing renal dysfunction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 10: Number of participants experiencing a cardiovascular event" data-id="CD012498-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 10: Number of participants experiencing a cardiovascular event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 11: Number of participants experiencing bleeding" data-id="CD012498-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 11: Number of participants experiencing bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 12: Number of participants experiencing thrombophlebitis" data-id="CD012498-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 12: Number of participants experiencing thrombophlebitis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 13: Number of participants reporting nausea" data-id="CD012498-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 13: Number of participants reporting nausea </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 14: Number of participants experiencing vomiting" data-id="CD012498-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 14: Number of participants experiencing vomiting </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Diclofenac versus placebo, Outcome 15: Number of participants with at least 50% pain relief at 6 hours: 18.75 mg" data-id="CD012498-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Diclofenac versus placebo, Outcome 15: Number of participants with at least 50% pain relief at 6 hours: 18.75 mg </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 1: Number of participants with at least 50% pain relief at 6 hours" data-id="CD012498-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 1: Number of participants with at least 50% pain relief at 6 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 2: Number of participants using rescue medication over 4 to 6 hours postinterventions" data-id="CD012498-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 2: Number of participants using rescue medication over 4 to 6 hours postinterventions </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 3: Number of participants withdrawing due to lack of efficacy" data-id="CD012498-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 3: Number of participants withdrawing due to lack of efficacy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 4: Number of participants withdrawing due to adverse events" data-id="CD012498-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 4: Number of participants withdrawing due to adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 5: Number of participants withdrawing for any cause" data-id="CD012498-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 5: Number of participants withdrawing for any cause </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 6: Number of participants reporting any adverse event" data-id="CD012498-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 6: Number of participants reporting any adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 7: Number of participants experiencing a serious adverse event" data-id="CD012498-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 7: Number of participants experiencing a serious adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 8: Number of participants experiencing renal dysfunction" data-id="CD012498-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 8: Number of participants experiencing renal dysfunction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 9: Number of participants experiencing a cardiovascular event" data-id="CD012498-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 9: Number of participants experiencing a cardiovascular event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 10: Number of participants experiencing bleeding" data-id="CD012498-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 10: Number of participants experiencing bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 11: Number of participants experiencing thrombophlebitis" data-id="CD012498-fig-0029" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 11: Number of participants experiencing thrombophlebitis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Diclofenac versus another NSAID, Outcome 12: Number of participants with at least 50% pain relief at 6 hours: 18.75 mg" data-id="CD012498-fig-0030" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: Diclofenac versus another NSAID, Outcome 12: Number of participants with at least 50% pain relief at 6 hours: 18.75 mg </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012498-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/urn:x-wiley:14651858:media:CD012498:CD012498-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Diclofenac high dose versus low dose, Outcome 1: Number of participants with at least 50% pain relief at 6 hours" data-id="CD012498-fig-0031" src="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_t/tCD012498-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Diclofenac high dose versus low dose, Outcome 1: Number of participants with at least 50% pain relief at 6 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/media/CDSR/CD012498/image_n/nCD012498-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012498-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intravenous diclofenac compared to placebo for acute postoperative pain in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intravenous diclofenac (37.5 mg to 75 mg) compared to placebo for acute postoperative pain in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries<br/><b>Settings:</b> Hospital or community<br/><b>Intervention:</b> Intravenous diclofenac (37.5 mg to 75 mg)<br/><b>Comparison:</b> Placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Probable outcome with</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect and NNTB or NNTH (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Diclofenac</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 4 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>228 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>643 per 1000</b><br/>(458 to 905) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.8</b> (2.0 to 4.0) </p> <p><b>NNTB 2.4</b> (1.9 to 3.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>277<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 6 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>336 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>592 per 1000</b><br/>(478 to 730) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.8</b> (1.4 to 2.2) </p> <p><b>NNTB 3.8</b> (2.9 to 5.9) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>436<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (or mean) time to use of rescue medication</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 80 minutes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 226 minutes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>542</p> <p>(5 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants using rescue medication over 4 to 6 hours postinterventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>810 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>478 per 1000</b><br/>(389 to 592) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.59</b> (0.48 to 0.73) </p> <p><b>NNTp</b> <b>3.0</b> (2.2 to 4.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>235<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants reporting any adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>709 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>702 per 1000</b><br/>(610 to 809) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> (0.86 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>296<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing a serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b><br/>(1 to 31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.0</b> (0.15 to 7.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>472<br/>(5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Studies underpowered to detect these events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome; NNTH: number needed to treat for an additional harmful outcome; NNTp: number needed to treat to prevent one event; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Unclear risk of bias in several domains.<br/><sup>2</sup>Unexplained heterogeneity.<br/><sup>3</sup>Total number of participants &lt; 400.<br/><sup>4</sup>Large magnitude of effect: RR &gt; 2.<br/><sup>5</sup>Imprecision: unable to estimate confidence intervals due to reporting of median data.<br/><sup>6</sup>Very low number of events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intravenous diclofenac compared to placebo for acute postoperative pain in adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012498-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous diclofenac compared to another NSAID for acute postoperative pain in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intravenous diclofenac (37.5 mg or 75 mg) compared to another NSAID for acute postoperative pain in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries<br/><b>Settings:</b> Hospital or community<br/><b>Intervention:</b> Intravenous diclofenac (37.5 mg or 75 mg) </p> <p><b>Comparison:</b> Another NSAID </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Probable outcome with</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect and NNTB or NNTH (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Another NSAID</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Diclofenac</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 4 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed as very low quality due to lack of data.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with at least 50% pain relief at 6 hours</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>767 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>721 per 1000</b><br/>(637 to 813) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> (0.83 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>360<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median (or mean) time to use of rescue medication</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 255 minutes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Median: 144 minutes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants using rescue medication over 4 to 6 hours postinterventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>470 per 1000</b><br/>(266 to 830) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.8</b> (1.0 to 3.3) </p> <p>NNTH <b>4.5</b> (2.5 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants reporting any adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>577 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>537 per 1000</b><br/>(473 to 612) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.93</b> (0.82 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing a serious adverse event</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b><br/>(1 to 32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> (0.13 to 6.6) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>423<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Studies underpowered to detect these events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome; NNTH: number needed to treat for an additional harmful outcome; NSAID: non‐steroidal anti‐inflammatory drug; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Unclear risk of bias in several domains.<br/><sup>2</sup>Total number of participants &lt; 400.<br/><sup>3</sup>Imprecision: unable to estimate confidence intervals due to reporting of median data.<br/><sup>4</sup>Fewer than 400 participants in unpublished studies required to change the NNTB to an unacceptably high level of 10.<br/><sup>5</sup>Very low number of events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous diclofenac compared to another NSAID for acute postoperative pain in adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/full#CD012498-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012498-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Diclofenac versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Number of participants with at least 50% pain relief at 4 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.82 [2.01, 3.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Number of participants with at least 50% pain relief at 6 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [1.42, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Number of participants using rescue medication over 4 to 6 hours postinterventions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.48, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Number of participants withdrawing due to lack of efficacy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.38, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Number of participants withdrawing due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.88 [0.43, 143.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Number of participants withdrawing for any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.39, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Number of participants reporting any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Number of participants experiencing a serious adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.15, 7.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Number of participants experiencing renal dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Number of participants experiencing a cardiovascular event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.15, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Number of participants experiencing bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.30, 2.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Number of participants experiencing thrombophlebitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.20, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Number of participants reporting nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.47, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Number of participants experiencing vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.26, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Number of participants with at least 50% pain relief at 6 hours: 18.75 mg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.24, 2.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Diclofenac versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012498-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Diclofenac versus another NSAID</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Number of participants with at least 50% pain relief at 6 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.83, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Number of participants using rescue medication over 4 to 6 hours postinterventions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Number of participants withdrawing due to lack of efficacy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Number of participants withdrawing due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [0.35, 10.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Number of participants withdrawing for any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.65, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Number of participants reporting any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.82, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Number of participants experiencing a serious adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.13, 6.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Number of participants experiencing renal dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Number of participants experiencing a cardiovascular event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.21, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Number of participants experiencing bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.28, 3.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Number of participants experiencing thrombophlebitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.12, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 Number of participants with at least 50% pain relief at 6 hours: 18.75 mg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.65, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Diclofenac versus another NSAID</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012498-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Diclofenac high dose versus low dose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Number of participants with at least 50% pain relief at 6 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.95, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Diclofenac high dose versus low dose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012498.pub2/references#CD012498-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012498.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012498-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012498-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012498-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012498-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012498-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012498-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012498-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD012498-note-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012498-note-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012498-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012498\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012498\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012498\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012498\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012498\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012498.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012498.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012498.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012498.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012498.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729639638"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012498.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729639642"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012498.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee1d0dd769377',t:'MTc0MDcyOTYzOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 